Neurocognitive and somatic stabilization inpediatric patients with severeMucopolysaccharidosis Type I
PMID: 29976218 Gene: IDUA Disease: MPS1 Inheritance: Autosomal recessive
Neurocognitive and somatic stabilization inpediatric patients with severeMucopolysaccharidosis Type I
PMID: 29976218 Gene: IDUA Disease: MPS1 Inheritance: Autosomal recessive
204
Case#: 204 14.8 yrs male, age at initial diagnosis 5 yrs DiseaseAssertion: MPS IH-S FamilyInfo:Nil CasePresentingHPOs: CaseHPOFreeText: CaseNotHPOs: CaseNotHPOFreeText: CaseEnzymeAssay: IDUA activity: low leukocyte IDUA enzyme activity CaseUrineGAGs: CaseERT: 9 yrs on ERT, then study drug, valanafusp alpha, also called AGT-181 for 12 months
CaseBMT: No PreviouslyPublished Don't know Variant1:p.R48del Variant1ClinVarID: 1518010 Variant1CAID: Variant2:p.P533R Variant2ClinVarID: 11910 Variant2CAID: CA256112
105
Case#: Pt 105 , Age 30 years, Female, DiseaseAssertion: MPS1 Scheie syndrome. FamilyInfo: NA CasePresentingHPOs: NA CaseHPOFreeText: NA CaseNotHPOs: NA CaseNotHPOFreeText: NA
CaseEnzymeAssay: Low leukocyte IDUA enzyme activity CaseUrineGAGs: NA CaseERT: No CaseBMT: No Variant1: p.R383H Variant1ClinVarID: 558189 Variant1CAID: Variant2:p.W402X Variant2ClinVarID: 11908 Variant2CAID: CA220498 AdditionalVariants: NA ParentalGenotype: NA PreviouslyPublished:NA
1/M
Case#: Patient 1, male, Russian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Severe intellectual disability, corneal clouding, skeletal deformities, hepatosplenomegaly (HP:0010864, HP:0007957, HP:0000924, HP:0001433)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 4.5 nmol/mg/h (reference range 135 ± 57 nmol/mg/h)
CaseUrineGAGs: 42.9 mg GAG/mmol/creatinine (reference range 6.17 ± 3.79 mg GAG/mmol creatinine)
CaseERT: No
CaseBMT: No
Variant1: c.208C>T (p.Q70X)
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: c.974insACCCCCATTTAC (p.Thr293_Tyr296dup) - in ClinVar this variant is listed as c.878_889dup12.
Variant2ClinVarID: 550382
Variant2CAID: CA2802114
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
6/M
Case#: Patient 6, male, Russian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Severe intellectual disability, corneal clouding, skeletal deformities, hepatosplenomegaly (HP:0010864, HP:0007957, HP:0000924, HP:0001433)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.06 nmol/mg/h (reference range 135 ± 57 nmol/mg/h)
CaseUrineGAGs: 238.7 mg GAG/mmol/creatinine (reference range 6.17 ± 3.79 mg GAG/mmol creatinine)
CaseERT: No
CaseBMT: No
Variant1: c.1162dupA (p.Thr388Asnfs*11)
Variant1ClinVarID: N/A
Variant1CAID: CA2586965961
Variant2: c.1162dupA (p.Thr388Asnfs*11)
Variant2ClinVarID: N/A
Variant2CAID: CA2586965961
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
distinct mutant IDUA alleles
Case#: Patient 44, Poland
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.208C>T (p.Q70X)
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: c.793G>C (p.G265R)
Variant2ClinVarID: 638074
Variant2CAID: CA2802098
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
distinct mutant IDUA alleles
Case#: Patient 90, Turkey, patient belong to the same geographical region as patients 86, 92, and 98
DiseaseAssertion: MPS1-H
FamilyInfo: Parents belong to the same village
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.494-1G>A
Variant1ClinVarID: 557942
Variant1CAID: CA355961634
Variant2: c.494-1G>A
Variant2ClinVarID: 557942
Variant2CAID: CA355961634
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
distinct mutant IDUA alleles
Case#: Patient 98, Turkey, patient belong to the same geographical region as patients 86, 90, and 92
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.494-1G>A
Variant1ClinVarID: 557942
Variant1CAID: CA355961634
Variant2: c.494-1G>A
Variant2ClinVarID: 557942
Variant2CAID: CA355961634
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
missense mutations
Case#: Patient 2, Italy
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.979G>C (p.A327P)
Variant1ClinVarID: 167190
Variant1CAID: CA234128
Variant2: c.979G>C (p.A327P)
Variant2ClinVarID: 167190
Variant2CAID: CA234128
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
26/F
Case#: Patient 26, female, Han origin, 3 years old (age at diagnosis)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Global Developmental Delay, Macrocephaly, Joint stiffness, Mongolian macula, Hepatosplenomegaly, Hernia, Airway obstruction (HP:0001263, HP:0000256, HP:0001387, HP:0011369, HP:0001433, HP:0100790, HP:0006536)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: 668insGCG, it looks like this should be c.665_667dup
Variant1ClinVarID: N/A
Variant1CAID: CA2586965942
Variant2: c.236C>T (p.A79V)
Variant2ClinVarID: 1458769
Variant2CAID: CA356987
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
24/M
Case#: Patient 24, male, Han origin, age not available
DiseaseAssertion: N/A
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 2.3 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: N/A
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: c.296+4G>A, it looks like this is a typo and should be c.299+4G>A
Variant2ClinVarID: N/A
Variant2CAID: CA2669476183
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
10/F
Case#: Patient 10, female, Han origin, 2.5 years old (age at diagnosis)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Global Developmental Delay, Macrocephaly, Joint stiffness, Hepatosplenomegaly, Airway obstruction (HP:0001263, HP:0000256, HP:0001387, HP:0001433, HP:0006536)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: Mongolian macula, Hernia (HP:0011369, HP:0100790)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.2 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.236C>T (p.A79V)
Variant1ClinVarID: 1458769
Variant1CAID: CA356987
Variant2: c.536C>G (p.T179R)
Variant2ClinVarID: 556358
Variant2CAID: CA355961718
AdditionalVariants: N/A
ParentalGenotype: Father - c.236C>T, Mother - c.536C>G. The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
11/M
Case#: Patient 11, male, Han origin, 7 years old (age at diagnosis)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: Macrocephaly, Joint stiffness, Hepatosplenomegaly, Hernia, Airway obstruction (HP:0000256, HP:0001387, HP:0001433, HP:0100790, HP:0006536)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: Global Developmental Delay, Mongolian macula (HP:0001263, HP:0011369)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.1 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.236C>T (p.A79V)
Variant1ClinVarID: 1458769
Variant1CAID: CA234128
Variant2: c.236C>T (p.A79V)
Variant2ClinVarID: 1458769
Variant2CAID: CA234128
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed by parental testing.
PreviouslyPublished N/A
12/F
Case#: Patient 12, female, Han origin, 13 years old (age at diagnosis)
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: Joint stiffness, Hepatosplenomegaly (HP:0001387, HP:0001433)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: Global Developmental Delay, Macrocephaly, Mongolian macula, Hernia, Airway obstruction (HP:0001263, HP:0000256, HP:0011369, HP:0100790, HP:0006536)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.0 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.536C>G (p.S633L)
Variant1ClinVarID: 556406
Variant1CAID: CA355966010
Variant2: c.536C>G (p.S633L)
Variant2ClinVarID: 556406
Variant2CAID: CA355966010
AdditionalVariants: N/A
ParentalGenotype: Father - c.536C>G, Mother - c.536C>G. The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed by parental testing.
PreviouslyPublished N/A
7/F
Case#: Patient 7, female, Han origin, 7 years old (age at diagnosis)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: Global Developmental Delay, Macrocephaly, Joint stiffness, Hepatosplenomegaly (HP:0001263, HP:0000256, HP:0001387, HP:0001433)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: Mongolian macula, Hernia, Airway obstruction (HP:0011369, HP:0100790, HP:0006536)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.3 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1227dupG (paper says c.1225dupC but according to the variant sequence this should be c.1227dupG - a known variant)
Variant1ClinVarID: 929237
Variant1CAID: CA1139658406
Variant2: c.236C>T (p.A79V)
Variant2ClinVarID: 1458769
Variant2CAID: CA356987
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
34/M
Case#: Patient 34, male, Han origin, 10 months old (age at diagnosis)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Global Developmental Delay, Macrocephaly, Joint stiffness, Mongolian macula, Hepatosplenomegaly, Hernia, Airway obstruction (HP:0001263, HP:0000256, HP:0001387, HP:0011369, HP:0001433, HP:0100790, HP:0006536)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 1.2 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.656dupG (Paper refers to the variant as c.657dupG, there is a typo in the article where all duplication variants are one base pair off)
Variant1ClinVarID: N/A
Variant1CAID: CA2586965940
Variant2: c.623G>A (p.G208D)
Variant2ClinVarID: 554590
Variant2CAID: CA355961948
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
44/M
Case#: Patient 44, male, Han origin, 21 years old (age at diagnosis)
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: Joint stiffness (HP:0001387)
CaseHPOFreeText: N/A
CaseNotHPOs: Global Developmental Delay, Macrocephaly, Mongolian macula, Hepatosplenomegaly, Hernia, Airway obstruction (HP:0001263, HP:0000256, HP:0011369, HP:0001433, HP:0100790, HP:0006536)
CaseNotHPOFreeText: Cardiac disease
CaseEnzymeAssay: IDUA activity 1.5 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.2T>C (p.Met1Thr)
Variant1ClinVarID: 639529
Variant1CAID: CA2801095
Variant2: c.1037T>G (p.L346R)
Variant2ClinVarID: 11927
Variant2CAID: CA256128
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
c.1898C>G/p.Ser633Trp Mutation in Alpha-l-Iduronidase: Clinical and Structural Implications
PMID: 33389473
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
30
Case#: Patient 30 (Table 3)
DiseaseAssertion: Severe naïve MPS 1
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 23 nmol/h/mg per DBS (dried blood spots) determined during NBS
CaseUrineGAGs: N/A
CaseERT: Yes
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA2204098
Variant2: c.1524+1G>T
Variant2ClinVarID: 555169
Variant2CAID: CA355964830
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 21, 2 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, recurrent infections (HP:0000280, HP:0001433, HP:0002719)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.9% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.935G>A (p.Trp312Ter)
Variant1ClinVarID: N/A
Variant1CAID: CA355962697
Variant2: c.935G>A (p.Trp312Ter)
Variant2ClinVarID: N/A
Variant2CAID: CA355962697
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 11, 4 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: Sibling of patient 10
CasePresentingHPOs: Coarse facial features, recurrent infections, dysostosis multiplex, intellectual disability, hernia (HP:0000280, HP:0002719, HP:0000943, HP:0001249, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 3.6% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.531C>G (p.Phe177Leu)
Variant1ClinVarID: 2432729
Variant1CAID: CA2801983
Variant2: c.531C>G (p.Phe177Leu)
Variant2ClinVarID: 2432729
Variant2CAID: CA2801983
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 39, 1 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Joint contractures, dysostosis multiplex (HP:0002828, HP:0000943)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 3.4% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1373T>C (p.Leu458Pro)
Variant1ClinVarID: N/A
Variant1CAID: CA355964255
Variant2: c.1373T>C (p.Leu458Pro)
Variant2ClinVarID: N/A
Variant2CAID: CA355964255
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 53, 2 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, corneal clouding, recurrent infections, intellectual disability, hernia (HP:0000280, HP:0001433, HP:0007957, HP:0002719, HP:0001249, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.5% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.502G>T (p.Gly168Ter)
Variant1ClinVarID: N/A
Variant1CAID: CA355961652
Variant2: c.1402+1G>A
Variant2ClinVarID: 555490
Variant2CAID: CA355964379
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 19, 1 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, joint contractures, corneal clouding, recurrent infections, dysostosis multiplex, hernia (HP:0000280, HP:0001433, HP:0002828, HP:0007957, HP:0002719, HP:0000943, HP:0100790)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.7% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.784delC (p.His262Thrfs*55)
Variant1ClinVarID: 956890
Variant1CAID: CA2802083
Variant2: c.784delC (p.His262Thrfs*55)
Variant2ClinVarID: 956890
Variant2CAID: CA2802083
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 49, 2 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, recurrent infections, dysostosis multiplex, hernia (HP:0000280, HP:0001433, HP:0002719, HP:0000943, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.7% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.(1189+1)(1190–1)(1959_?)del in the paper, unsure how to write this in current nomenclature.
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: c.(1189+1_1190-1)(2003?)del in the paper, unsure how to write this in current nomenclature.
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 47, 2 years old (age at report), female, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 1.8% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.(792+1_793-1)_(972+1_973-1)del in the paper, unsure how to write this in current nomenclature.
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: c.(792+1_793-1)_(972+1_973-1)del in the paper, unsure how to write this in current nomenclature.
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 46, 9 years old (age at report), female, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, joint contractures (HP:0000280, HP:0001433, HP:0002828)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.0% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1898C>T (p.Ser633Leu)
Variant1ClinVarID: 556406
Variant1CAID: CA355966010
Variant2: c.1898C>T (p.Ser633Leu)
Variant2ClinVarID: 556406
Variant2CAID: CA355966010
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 36, 6 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, joint contractures, corneal clouding, recurrent infections, dysostosis multiplex, intellectual disability, hernia (HP:0000280, HP:0001433, HP:0002828, HP:0007957, HP:0002719, HP:0000943, HP:0001249, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.5% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1373T>C (p.Leu458Pro)
Variant1ClinVarID: N/A
Variant1CAID: CA355964255
Variant2: c.1373T>C (p.Leu458Pro)
Variant2ClinVarID: N/A
Variant2CAID: CA355964255
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
PMID: 8328452
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Case#: Patient M3, Muslim religious group, located in Gaza. The cells of the patient were listed in the catalog of the Human Genetic Mutant Cell Repository as "Hurler/Scheie". However, the patient at age 6 years had been described as having a typical MPS1-H phenotype except for apparently normal intelligence (measured across a language barrier).
DiseaseAssertion: MPS1-H/S or MPS1-H
FamilyInfo: Parents were found to have both mutations were found in heterozygous form in the DNA. Affected brother deceased at age 9.
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1225G>A (p.G409R)
Variant1ClinVarID: 1084956
Variant1CAID: CA91169920
Variant2: (p.X654C)
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
D1
Case#: Patient D1, Druze religious group, located in lower Galilee.
DiseaseAssertion: MPS1-H
FamilyInfo: Both parents, as well as an aunt and uncle who had a deceased affected child, were heterozygous for the same mutation.
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.192C>A (p.Y64X)
Variant1ClinVarID: 11914
Variant1CAID: N/A
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
14/M
Case#: 14, Male, 24 months (onset), 3 years (diagnosed), 8 years (report), deceased (at 9y)
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0004322, HP:0000256, HP:0001387, HP:0002240, HP:0001744, HP:0001638, HP:0000023, HP:0002415, HP:0000158, HP:0000280, HP:0000943, HP:0007957 (Short Stature, Macrocephaly, Joint Stiffness, Hepatomegaly (severe), Splenomegaly (moderate), Cardiomyopathy (involvement of valves), Inguinal Hernia, Leukodystrophy (in MRI), Large Tongue, Coarse Facial Features, Dysostosis Multiplex, Corneal Clouding)
CaseHPOFreeText: (Mental Development (Delayed since infancy), Vision and Hearing impairment, Ear Inflammations, Cervical Canal Stenosis (in MRI at 7y), Tracheostomy)
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Not Provided
Variant1: p.Q70X
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: p.W626X
Variant2ClinVarID: 928997
Variant2CAID: CA355965968
AdditionalVariants: p.Q33H/Q33H, p.L118
ParentalGenotype: N/A
PreviouslyPublished N/A
Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C-terminus of the IDUA protein
PMID: 19396826
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
12/F
Case#: 12, Female, 5 months (onset), 5 years (diagnosed), 5 years (report), deceased (at 7y)
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0004322, HP:0000256, HP:0001387, HP:0002240, HP:0001744, HP:0001537, HP:0000365, HP:0000280, HP:0000943, HP:0007957 (Short Stature, Macrocephaly, Joint Stiffness, Hepatomegaly (Severe), Splenomegaly (moderate), Umbilical Hernia, Deafness (progressive), Coarse Facial Features, Dysostosis Multiplex, Corneal Clouding)
CaseHPOFreeText: Mental Development (Delayed)
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Not Provided
Variant1: p.Q70X
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: p.D315Y
Variant2ClinVarID: N/A
Variant2CAID: CA355962740
AdditionalVariants: p.A8, p.A20, p.Q33H, p.L118
ParentalGenotype: N/A
PreviouslyPublished N/A
9/F
Case#: 9, Female, 3-4 years (onset), 4 years (diagnosed), 20 years (report), deceased (accidentally at 21y)
DiseaseAssertion: Hurler-Scheie Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0000256, HP:0001387, HP:0002240, HP:0001744, HP:0001639, HP:001285, HP:0000158, HP:0000280, HP:0000943, HP:0007957 (Macrocephaly, Joint Stiffness (Severe and progressive), Hepatomegaly (Severe at diagnosis but none at report), Splenomegaly (mild at diagnosis and report), Hypertrophic Cardiomyopathy (Progressive), Carpal tunnel syndrome, Large Tongue, Coarse Facial Features, Dysostosis Multiplex, Corneal Clouding)
CaseHPOFreeText: Mental Development (Uneven Development at 2y; IQ 117 at 12y)
CaseNotHPOs: HP:0004322 (Short Stature)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: ERT since 18y
CaseBMT: N/A
GenotypingMethod: Not Provided
Variant1: p.W402X
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: p.E640fs
Variant2ClinVarID: 558359
Variant2CAID: CA355966048
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
20/F
Case#: 20, Female, infancy (onset), 2 years (diagnosed), 2 years (report)
DiseaseAssertion: Hurler Syndrome
FamilyInfo: N/A
CasePresentingHPOs: HP:0004322, HP:0002240, HP:0001744, HP:0000280, HP:0000943, HP:0007957 (Short Stature, Hepatomegaly, Splenomegaly, Coarse Facial Features, Dysostosis Multiplex, Corneal Clouding)
CaseHPOFreeText: (Mental Development (delayed since early infancy), Mild LV hypertrophy, Frequent respiratory infections, Vision Impairment and Hearing Loss)
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Not Provided
Variant1: p.V620F
Variant1ClinVarID: 1067173
Variant1CAID: CA355965934
Variant2: p.V620F
Variant2ClinVarID: 1067173
Variant2CAID: CA355965934
AdditionalVariants: p.R105Q/R105Q, p.N181/N181, p.A314/A314, p.A361T/A361T, p.T388/T388, p.T410/T410, p.V454I/V454I, p.R489/R489
ParentalGenotype: N/A
PreviouslyPublished N/A
c.1576C>A
Case#: Functional assay variant with a clinical significance of being a VUS. Variant not found in patients but generated to compare with p.L526P
DiseaseAssertion: MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1576C>A (p.L326M)
Variant1ClinVarID: N/A
Variant1CAID: CA355964993
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
c.235G>A
Case#: Functional assay variant with a clinical significance of clinically benign.
DiseaseAssertion: MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.235G>A (p.A79T)
Variant1ClinVarID: 195038
Variant1CAID: CA201508
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
c.1709A>T
Case#: Functional assay variant with a clinical significance of being likely pathogenic.
DiseaseAssertion: MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1709A>T (p.D570V)
Variant1ClinVarID: 1980496
Variant1CAID: CA355965255
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
c.298A>G
Case#: Functional assay variant with a clinical significance of being a VUS.
DiseaseAssertion: MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.298A>G (p.R100G)
Variant1ClinVarID: 2058952
Variant1CAID: CA2801159
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
c.757G>T
Case#: Functional assay variant with a clinical significance of having conflicting interpretations.
DiseaseAssertion: MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.757G>T (p.G253C)
Variant1ClinVarID: 554213
Variant1CAID: CA2802076
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
patient 2662
Case#: Patient 2662, northern European origin, 11 years old (age of diagnosis), 22 years old (age at report), male, attended special schools until 15 years old, has not attained the ability to read and write, and has an increasingly poor memory.
DiseaseAssertion: MPS-1H/S, intermediate
FamilyInfo: Two affected younger sisters with MPS1 who presumably have the same R89Q/1060+2t-*-c genotype. he youngest sister died of bronchopneumonia at 22 mo of age. His second sister presented at 2 years and 6 mo of age with good general health, apart from upper respiratory tract infection, coarse facial features, enlarged liver and spleen, and limitation of elbow extension. This sister is now 20 years of age, has coarse facial features and joint limitations, is obese, and has a short stature. She is "bright" and able to live in her own flat with visiting help.
CasePresentingHPOs: Intellectual disability, memory impairment, limited motor development, severe joint contractures, short stature, obesity, macrocephaly, coarse facial features, hearing impairment, visual impairment (HP:0001249, HP:0002354, HP:0002194, HP:0002828, HP:0004322, HP:0001513, HP:0000256, HP:0000280, HP:0000365, HP:0000505)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Fibroblasts with two monoclonal antibodies detected 7%-10% of the normal levels of IDUA protein compared with only 1.5% of IDUA protein in a R89Q/W402X compound heterozygote
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.266G>A (p.R89Q)
Variant1ClinVarID: 11922
Variant1CAID: CA256124
Variant2: c.972+2T>C (1060+2T>C)
Variant2ClinVarID: N/A
Variant2CAID: CA355962890
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Patient #2 (see Table 2), male, 2 years old (age at diagnosis), 12 years old (age at report)
DiseaseAssertion: MPS-I
FamilyInfo: Born from a consanguineous marriage
CasePresentingHPOs: Cardiomyopathy, scoliosis, macroglossia, failure to thrive, global developmental delay, short stature, skeletal dysplasia, hepatomegaly, splenomegaly (HP:0001638, HP:0002650, HP:0000158, HP:0001508, HP:0001263, HP:0004322, HP:0002652, HP:0002240, HP:0001744)
CaseHPOFreeText: Normal intelligence, mitral valve thickening
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: α-L-iduronidase 0.5 nmol/ml. The activity of this enzyme is below its reference (1–18.5 nmol/ml).
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.903C>G (p.D301E)
Variant1ClinVarID: 1458511
Variant1CAID: CA355962528
Variant2: c.903C>G (p.D301E)
Variant2ClinVarID: 1458511
Variant2CAID: CA355962528
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Patient #1 (see Table 2), male, 6 months old (age at diagnosis), 7 years old (age at report)
DiseaseAssertion: MPS I
FamilyInfo: Born from a consanguineous marriage
CasePresentingHPOs: Scoliosis, developmental delay, short stature, macrocephaly, coarse facial features, hepatomegaly (HP:0002650, HP:0001263, HP:0004322, HP:0000256, HP:0000256, HP:0002240)
CaseHPOFreeText: Irregular chest, respiratory problems
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: α-L-iduronidase 1.18 nmol/spot. The activity of this enzyme is below its reference (450–2600 nmol/spot).
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.469T>C (p.S157P)
Variant1ClinVarID: N/A
Variant1CAID: CA355961573
Variant2: c.469T>C (p.S157P)
Variant2ClinVarID: N/A
Variant2CAID: CA355961573
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
exon 7 (Gln310-->Ter)
Case#: Bach Patient D2, Israel, Druze
DiseaseAssertion: MPS I, Hurler
FamilyInfo: parents are het carriers
CasePresentingHPOs:
CaseHPOFreeText: Severe disease described as: "manifested from late infancy by dysostosis multiplex, coarse facies, corneal opacities, cardiovascular disease, hepatosplenomegaly, joint stiffness, and mental retardation; death usually occurs in the first decade of life." However, no specific information provided about proband. Level of mRNA in patient fibroblasts was half that of the normal control after normalization for beta-actin
CaseNotHPOs:
CaseNotHPOFreeText:
GenotypingMethod: PCR amplification of reverse-transcribed RNA or genomic DNA segments, cycle sequencing of PCR products, and restriction-enzyme analysis
PreviouslyPublished: preliminary account of this data summarized in a previous abstract: PMID: 8477267
Variant: Gln310Ter homozygous
CAID: CA256115
SupplementalData: n/a
I
Case#: Patient I, origin of patient is Germany/Italy
DiseaseAssertion: Hurler syndrome (H)
FamilyInfo: No family information stated in this paper
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: 0 nmol/mghour IDUA enzyme activity in patient. Reference range of IDUA enzyme is 0.27 - 9.00 nmol/mghour. These results obtained from leucocyte
CaseUrineGAGs: Information not stated in this paper
CaseERT: Don't know
CaseBMT: Don't know
Variant1: c.973‐7C>G
Variant1ClinVarID:
Variant1CAID: CA2586965950
Variant2: Not identified in this study
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: No additional variants mentioned
ParentalGenotype: No parental information provided
PreviouslyPublished: States that this variant is reported in this paper for the first time, therefore I do not believe the patient has been previously published
14
Case#: Patient 14, male, 10 years (age at presentation).
DiseaseAssertion: MPS1-H/S
FamilyInfo: Consanguinity in the family not present for this patient.
CasePresentingHPOs: Corneal clouding, coarse facial features, dystosis multiplex, hepatomegaly, joint contractures, short stature (HP:0007957, HP:0000256, HP:0000943, HP:0002240, HP:0100790, HP:0004322)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.158+5delinsAA
Variant1ClinVarID: N/A
Variant1CAID: CA2586973515
Variant2: c.895G>T (p.E299X)
Variant2ClinVarID: 987878
Variant2CAID: CA355962511
AdditionalVariants: N/A
ParentalGenotype: Father was a carrier for c.158+5delGClinsAA (also written as c.158+5delinsAA); mother was a carrier for c.895G>T
PreviouslyPublished N/A
18
Case#: Patient 18, male, 2 years (age at presentation).
DiseaseAssertion: MPS1-H
FamilyInfo: Consanguinity in the family present for this patient.
CasePresentingHPOs: Corneal clouding, coarse facial features, dystosis multiplex, global developmental delay, hepatomegaly, joint stiffness, Mongolian blue spots, splenomegaly (HP:0007957, HP:0000256, HP:0000943, HP:0001263, HP:0002240, HP:0001387, HP:0011369, HP:0001744)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1096_1099delACCG (p.Thr366Argfs*73)
Variant1ClinVarID: 1065522
Variant1CAID: CA2499217017
Variant2: c.1096_1099delACCG (p.Thr366Argfs*73)
Variant2ClinVarID: 1065522
Variant2CAID: CA2499217017
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
9
Case#: Patient 9, female, 1 year (age at presentation).
DiseaseAssertion: MPS1-H
FamilyInfo: Consanguinity in the family present for this patient.
CasePresentingHPOs: Corneal clouding, coarse facial features, dysostosis multiplex, global developmental delay, hepatomegaly, joint stiffness, splenomegaly, recurrent respiratory infections, umbilical hernia (HP:0007957, HP:0000256, HP:0000943, HP:0001263, HP:0002240, HP:0001387, HP:0001744, HP:0002205, HP:0001537)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.362T>C (p.L121P)
Variant1ClinVarID: 1343382
Variant1CAID: CA355961174
Variant2: c.362T>C (p.L121P)
Variant2ClinVarID: 1343382
Variant2CAID: CA355961174
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
7
Case#: Patient 7, male, 1 month (age at presentation).
DiseaseAssertion: MPS1-H
FamilyInfo: Consanguinity in the family not present for this patient. Family conducted a prenatal diagnosis on the next pregnancy and CVS to be unaffected
CasePresentingHPOs: Corneal clouding, coarse facial features, dysostosis multiplex, global developmental delay, hepatomegaly, joint stiffness, splenomegaly, umbilical hernia (HP:0007957, HP:0000256, HP:0000943, HP:0001263, HP:0002240, HP:0001387, HP:0001744, HP:0001537)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.362T>C (p.L121P)
Variant1ClinVarID: 1343382
Variant1CAID: CA355961174
Variant2: c.362T>C (p.L121P)
Variant2ClinVarID: 1343382
Variant2CAID: CA355961174
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: L535F
Variant1ClinVarID: 638076
Variant1CAID: CA355965038
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: N348K
Variant1ClinVarID:
Variant1CAID: CA355963142
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: L238Q
Variant1ClinVarID: 265418
Variant1CAID: CA2802065
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: V279A
Variant1ClinVarID:
Variant1CAID: CA355962380
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: T103P
Variant1ClinVarID:
Variant1CAID: CA355960996
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: G409R
Variant1ClinVarID: 1084956
Variant1CAID: CA91169920
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: S633L
Variant1ClinVarID: 556406
Variant1CAID: CA355966010
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Variant 10 of 11
Variant1:NM_000203.3: c.568_581del p.(Asn190Hisfs*204)
Variant1CAID:CA2801994
Variant 9 of 11
Variant1:NM_000203.3: c.494-1G>C
Variant1CAID:CA275298
An integrated multiomic approach as an excellent tool for the diagnosis of metabolic diseases: our first 3720 patients
PMID:35614200
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
A list of 11 IDUA variants identified in cases with MPS is included in Supplemental Table 6, but the variants are not linked to specific patients and are listed individually (not as genotypes). A page note has been added for each variant.
Variant 8 of 11
Variant1:NM_000203.3: c.395T>C p.(Leu132Pro)
Variant1CAID:CA355961295
294
Case#: Patient 29 (see Table 2), 40 weeks, 5 days (Gestational age)
DiseaseAssertion: MPS1-S
FamilyInfo: Sibling of Patient 28 (see Table 2)
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: Upper respiratory tract involvement
CaseEnzymeAssay: 1.61 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.474-2A>G (new nomenclature: c.386-2A>G)
Variant1ClinVarID: 222994
Variant1CAID: CA356991
Variant2: c.1148G>A (p.R383H)
Variant2ClinVarID: 558189
Variant2CAID: CA:2802205
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life
PMID: 23837464
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
201
Case#: Patient 20 (see Table 2), 37 weeks, 1 day (Gestational age)
DiseaseAssertion: MPS1-H/S
FamilyInfo: Sibling of Patient 19 (see Table 2)
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: Upper respiratory tract involvement
CaseEnzymeAssay: 0.95 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1044C>A (p.N348K)
Variant2ClinVarID: N/A
Variant2CAID: CA:355963142
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
9
Case#: Patient 9 (see Table 2), 37 weeks, 2 days (Gestational age)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: Upper respiratory tract involvement
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.208C>T (p.Q70X)
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: c.653T>C (p.L218P)
Variant2ClinVarID: 222995
Variant2CAID: CA:356986
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
21
Case#: Patient 21 (see Table 2), 41 weeks, 2 days (Gestational age)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: Upper respiratory tract involvement
CaseEnzymeAssay: 0.35 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.653T>C (p.L218P)
Variant1ClinVarID: 222995
Variant1CAID: CA356986
Variant2: c.943G>T (p.D315Y)
Variant2ClinVarID: N/A
Variant2CAID: CA:355962740
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
18
Case#: Patient 18 (see Table 2), 40 weeks (Gestational age)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: Upper respiratory tract involvement
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.77 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1513C>G (p.R505G)
Variant2ClinVarID: 1482722
Variant2CAID: CA:355964784
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
284
Case#: Patient 28 (see Table 2), 40 weeks, 5 days (Gestational age)
DiseaseAssertion: MPS1-S
FamilyInfo: Sibling of Patient 29 (see Table 2)
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: Upper respiratory tract involvement
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.474-2A>G (new nomenclature:c.386-2A>G)
Variant1ClinVarID: 222994
Variant1CAID: CA356991
Variant2: c.1148G>A (p.R383H)
Variant2ClinVarID: 558189
Variant2CAID: CA:2802205
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
13
Case#: Patient 13 (see Table 2), 38 weeks, 3 days (Gestational age)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: Upper respiratory tract involvement
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.43 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.653T>C (p.L218P)
Variant2ClinVarID: 222995
Variant2CAID: CA:356986
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
4
Case#: Infant 4
DiseaseAssertion: N/A
FamilyInfo: Has an older sibling who is asymptomatic, has normal urine GAGs, and shares the same genotype.
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.2 nmol/h/mg; normal range, 6-71.4 nmol/h/mg
CaseUrineGAGs: 18.61 mg/mmol creatinine; normal ranges, 0-53 mg/mmol creatinine. Heparan sulfate was slightly elevated at 7.46 g/mol creatinine (normal, 0-5.71 g/mol creatinine) in 2 separate specimens.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.720C>G (p.H240Q)
Variant1ClinVarID: 1011483
Variant1CAID: CA355962130
Variant2: c.1112T>A (p.V371D)
Variant2ClinVarID: 1470032
Variant2CAID: CA355963356
AdditionalVariants: N/A
ParentalGenotype: c.720C>G (maternal); c.1112T>A (paternal)
PreviouslyPublished N/A
1
Case#: Infant 1
DiseaseAssertion: N/A
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 5.1 nmol/h/mg; normal range, 15.1-50.9 nmol/h/mg
CaseUrineGAGs: 22.6 mg/mmol creatinine; normal ranges, 0-53 mg/mmol creatinine
CaseERT: N/A
CaseBMT: N/A
Variant1: c.298A>G (p.R100G)
Variant1ClinVarID: 2058952
Variant1CAID: CA2801159
Variant2: c.300-20C>T
Variant2ClinVarID: 1415135
Variant2CAID: CA2801857
AdditionalVariants: c.1345C>A (p.H449N)
ParentalGenotype: c.298A>G (maternal); c.300-20C>T (paternal); c.1345C>A (paternal)
PreviouslyPublished N/A
4
Case#: Patient 4 was biochemically diagnosed with MPS I because they showed an increase in urinary GAGs and a reduction in IDUA activity in leukocytes. Patient 4 was diagnosed at 2 years and 7 months.
DiseaseAssertion: MPSI-H/S
FamilyInfo: N/A
CasePresentingHPOs: Coarse facies, corneal clouding, hernias, skeletal abnormalities, cardiac abnormalities, and hepatosplenomegaly (HP:0000256, HP:0007957, HP:0100790, HP:0002360, HP:0001627, HP:0001433)
CaseHPOFreeText: N/A
CaseNotHPOs: Intellectual disability, growth delay (HP:0001249, HP:0001510)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity of 6.5 nmol/mg/protein/hr. No reference range provided.
CaseUrineGAGs: 202.8 CPC unit/g creatinine. No reference range provided.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.236C>T (p.A79V)
Variant1ClinVarID: 1458769
Variant1CAID: CA356987
Variant2: c.1882C>T (p.R628X)
Variant2ClinVarID: 550421
Variant2CAID: CA2802462
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
P4-IDUAFEuropeanItaly1.43.8IDUAc.246C > G/c.1716C > Gp.His82Gln/p.His572GlnMissenseMissensePseudo/VUS
Case#: P4-IDUA, F, European, Italy DiseaseAssertion: MPS1 - Pseudo/VUS FamilyInfo: CasePresentingHPOs: CaseHPOFreeText: CaseNotHPOs: CaseNotHPOFreeText: CaseEnzymeAssay: NBS 1.4 triplex / 3.8 single CaseUrineGAGs: CaseERT: CaseBMT: Variant1: c.246C>G Variant1ClinVarID: 92637 Variant1CAID: CA220506 Variant2: c.1716C>G Variant2ClinVarID: 1431214 Variant2CAID: CA355965272 AdditionalVariants: ParentalGenotype: PreviouslyPublished
P2-IDUAMNorth AfricaMorocco0.964.2IDUAc.246C > G/c.1757C > Tp.His82Gln/p.Ser586PheMissenseMissensePseudo/VUS
Case#: P2-IDUA, M, North Africa, Morocco DiseaseAssertion: MPS1 - Psuedu/VUS FamilyInfo: CasePresentingHPOs: CaseHPOFreeText: CaseNotHPOs: CaseNotHPOFreeText: CaseEnzymeAssay: NBS 0.96 triplex / 4.2 single CaseUrineGAGs: CaseERT: CaseBMT: Variant1: c.246C>G Variant1ClinVarID: 92637 Variant1CAID: 92637 Variant2: c.1757C>T Variant2ClinVarID: 571910 Variant2CAID: CA2802396 AdditionalVariants: ParentalGenotype: PreviouslyPublished
Abnormal
Case#: No additional case information provided.
DiseaseAssertion: Not specified
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Abnormal
CaseUrineGAGs: Normal
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1042_1062dup
Variant1ClinVarID: 2432708
Variant1CAID: CA549264534
Variant2: c.986A>G
Variant2ClinVarID: N/A
Variant2CAID: CA2802157
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Abnormal
Case#: No additional case information provided
DiseaseAssertion: Not specified
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Abnormal
CaseUrineGAGs: Normal
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1051G>A (p.A351T)
Variant1ClinVarID: 967585
Variant1CAID: CA2802176
Variant2: c.497G>C (p.R166T)
Variant2ClinVarID: 1388155
Variant2CAID: CA2801967
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
NP
Case#: No additional case information provided
DiseaseAssertion: Not specified
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Not performed
CaseUrineGAGs: Normal
CaseERT: N/A
CaseBMT: N/A
Variant1: c.53T>C (p.L18P)
Variant1ClinVarID: 193062
Variant1CAID: CA238566
Variant2: c.1651G>C (p.V551L)
Variant2ClinVarID: 1410776
Variant2CAID: CA2802341
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
7
Case#: Patient 7 (see Table 2), male, 15.1 years old (age at report), 6.9 years (duration of treatment), 6 surgeries
DiseaseAssertion: MPS1-HS
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: HP:0000238, HP:0002176, HP:0002360 (Hydrocephalus, spinal cord compression, sleep abnormality)
CaseNotHPOFreeText: Shunt placement, psychiatric problems
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes
CaseBMT: N/A
Variant1: (p.G256R) Potential type error, p.G256R does not exist, possible should be p.G265R as seen in Patient 8.
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
12
Case#: Patient 12 (see Table 2), female, 20.9 years old (age at report), 9.3 years (duration of treatment), 10 surgeries
DiseaseAssertion: MPS1-HS
FamilyInfo: N/A
CasePresentingHPOs: HP:0002176 (Spinal cord compression)
CaseHPOFreeText: N/A
CaseNotHPOs: HP:0000238, HP:0002360 (Hydrocephalus, sleep abnormality)
CaseNotHPOFreeText: Shunt placement
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: (Int11-7c>t) Current HGVS nomenclature is c.1651-7C>T
Variant2ClinVarID: 1147380
Variant2CAID: CA438057995
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Patient 3
Case#:3. 0.7 year Male, diagnosed at 0.4 years DiseaseAssertion:MPS1H FamilyInfo:NA CasePresentingHPOs:NA CaseHPOFreeText:NA CaseNotHPOs:NA CaseNotHPOFreeText:NA CaseEnzymeAssay:Undetectable CaseUrineGAGs:NA CaseERT:NA CaseBMT:Yes, Unrelated cord blood, Post HSCT 18.2 nmol/h/mg of protein ( α-l-Iduronidase Levels) Variant1:IDUA : c.178C>T Variant1ClinVarID:655054 Variant1CAID: Variant2:IDUA: c.1205G>A Variant2ClinVarID: 11908 Variant2CAID:CA220498 AdditionalVariants: ParentalGenotype: PreviouslyPublished
younger sibling
Case#: YS of sibship 9, female, 6.7 years old (age at diagnosis), 8.6 years old (age at ERT enrollment), 6.4 years (duration of ERT)
DiseaseAssertion: MPS1-HS
FamilyInfo: Affected OS (OS of sibship 9)
CasePresentingHPOs: HP:0007957, HP:0000943, HP:0002828 (Corneal opacity, dysostosis, joint contracture)
CaseHPOFreeText: Cardiac disease, ocular, respiratory, and musculoskeletal involvement.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - Had stabilization of mild ocular symptoms, and cardiac disease remained less severe in the mild to moderate range. Had stabilization of dysostosis multiplex and no progression of motor function delays.
CaseBMT: N/A
Variant1: N/A
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
younger patient
Case#: YS of Sibship 1, male, 0.2 years old (age at diagnosis), 0.3 years old (age at ERT enrollment), 4.5 years (duration of ERT)
DiseaseAssertion: MPS1-HS
FamilyInfo: Affected female OS (OS of sibship 1).
CasePresentingHPOs: Hernia (HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: HP:0007957, HP:0000943, HP:0002828 (Corneal opacity, dysostosis, joint contractures)
CaseNotHPOFreeText: Cardiac disease
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - after almost 5 years of ERT, there was no development of cardiac or musculoskeletal disease.
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
sibling who began ERT at <1 year of age
Case#: YS1 of sibship 5 (see Table 1), male, 0.1 years old (age at diagnosis), 0.3 years old (age at ERT enrollment), 7.6 years (duration of ERT)
DiseaseAssertion: MPS1-HS
FamilyInfo: Two affected siblings (OS and YS2 of sibship 5)
CasePresentingHPOs: HP:0007957 (Corneal opacity)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: HP:0000943, HP:0002828 (Dysostosis, joint contractures)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - Remained healthy, with the exception of mild ocular and cardiac symptoms. Psychomotor development remained normal and there were no limitations in ADL. Pulmonary function was between 70 and 94 % of normal at T2.
CaseBMT: N/A
Variant1: c.1469T>C (p.L490P)
Variant1ClinVarID: 11919
Variant1CAID: CA220503
Variant2: c.1469T>C (p.L490P)
Variant2ClinVarID: 11919
Variant2CAID: CA220503
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
the youngest
Case#: YS of sibship 6 (see Table 1), male, 0.6 years old (age at diagnosis), 3 years old (age at ERT enrollment), 7 years (duration of ERT)
DiseaseAssertion: MPS-HS
FamilyInfo: Two affected siblings (OS1 and OS2 of sibship 6)
CasePresentingHPOs: HP:0007957, HP:0000943, HP:0002828 (Corneal opacity, dysostosis, joint contractures)
CaseHPOFreeText: Cardiac disease, musculoskeletal symptoms
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - Pulmonary function was 70–80 % of normal and had no restrictions in ADL.
CaseBMT: N/A
Variant1: N/A
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships
PMID: 26446585
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of alpha-l-iduronidase mutations causing mucopolysaccharidosis type I
PMID: 19954743
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
10 MPS I patients
Case#: MPS 1 patient
DiseaseAssertion: N/A
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.208C>T (p.Q70X)
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: c.943G>T (p.D315Y)
Variant2ClinVarID: 4539822
Variant2CAID: CA355962740
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Patient 3, 4 years old, Iranian
DiseaseAssertion: MPS1-H (Severe)
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity not detected
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
A novel compound mutation in alpha-L-iduronidase gene causes mucopolysaccharidosis type I
PMID: 31544795
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
5
Case#: Patient No. 5 (Table 1), Black race, male, 2.84 years old (age at time of gene therapy), 77 IQ score, 2.18 years since gene therapy (2 years since latest visit). An acute hypersensitivity reaction that occurred in Patient 5 on day 12 after HSPC gene therapy and concomitantly to a first administration of vancomycin was considered by the investigators to be probably related to HSPC gene therapy. The event resolved promptly after treatment with antihistamines, intravenous fluids, and glucocorticoids, with no sequelae.
DiseaseAssertion: MPS-IH
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: Yes
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1409delT (p.V470AfsX?)
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: CA-106 ID number, Table S1.1 of Supplementary Material. Male, 5 months old (age at first symptoms), 6.5 months old (age at diagnosis). Stored frozen (-20ºC) 1.3 yr
DiseaseAssertion: Severe MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: Bump on back, chronic breathing problems, moderate-severe hearing loss.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: 1351 fmol/punch
CaseERT: N/A
CaseBMT: Yes - In April 2018
Variant1: N/A
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: CA-120 ID number, Table S1.1 of Supplementary Material. Female, 8 months old (age at first symptoms), 9 years and 6 months old (age at diagnosis). Stored frozen (-20ºC) 28 yr. May be the sibling of CA-119 due to closeness in ID numbers as well as having the same variants.
DiseaseAssertion: Attenuated MPS-I
FamilyInfo: N/A
CasePresentingHPOs: Ear infections (12 sets of tubes), hernia, joint contractures (HP:0410018, HP:0100790, HP:0100790)
CaseHPOFreeText: Perri Robin Syndrome, Adenoids removed (2x). Heart Valves, Spine, Contractures (No additional information provided about these symptoms).
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: 399 fmol/punch
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1651-7C>T
Variant1ClinVarID: 1147380
Variant1CAID: CA438057995
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Mucopolysaccharidosis type I newborn screening: Importance of second tier testing for ethnically diverse populations Kerri Bosfield, Kerri Bosfield orcid.org/0000-0001-5135-3779 Children's National Hospital, Washington, DC, USASearch for more papers by this authorDebra S. Regier, Corresponding Author Debra S. Regier dregier@childrensnational.org orcid.org/0000-0001-7525-0088 Children's National Hospital, Washington, DC, USA Correspondence Debra S. Regier, Children's National Hospital, 111 Michigan Ave NW, Washington, DC 20010, USA. Email: dregier@childrensnational.orgSearch for more papers by this authorSarah Viall, Sarah Viall Children's National Hospital, Washington, DC, USASearch for more papers by this authorRebecca Hicks, Rebecca Hicks Children's National Hospital, Washington, DC, USASearch for more papers by this authorNatasha Shur, Natasha Shur orcid.org/0000-0003-1336-747X Children's National Hospital, Washington, DC, USASearch for more papers by this authorChristina L. Grant, Christina L. Grant Children's National Hospital, Washington, DC, USASearch for more papers by this author
PMID: 33098355
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
A319V
Case#: Family 26, Pakistan
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: The Scheie phenotype is characterized by aortic valve disease, corneal clouding, limited skeletal problems, but no mental retardation. This is a general assessment and not specific to this patient.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
α-L-iduronidase activity in COS-7 cells transiently transfected with wild-type or mutagenised cDNAs. α-L-iduronidase activity: 5.2 nmol/h/mg cell protein; values are the means of two experiments.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.956C>T (p.A319V)
Variant1ClinVarID: 1683230
Variant1CAID: CA2802126
Variant2: c.956C>T (p.A319V)
Variant2ClinVarID: 1683230
Variant2CAID: CA2802126
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
740delC
Case#: Family 18, Slovenia
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: The paper states that "Hurler form is characterized by skeletal abnormalities, hepatosplenomegaly and severe mental retardation" but is not specific to this patient.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.652delC; c.740delC in the paper (old nomenclature)
Variant1ClinVarID: N/A
Variant1CAID: CA2586965939
Variant2: c.652delC; c.740delC in the paper (old nomenclature)
Variant2ClinVarID: N/A
Variant2CAID: CA2586965939
AdditionalVariants: N/A
ParentalGenotype: Parental testing conducted, each parent was shown to carry one of the sequence changes found in their affected child.
PreviouslyPublished N/A
W402X
Case#: Family 6, UK
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: The paper states that "Hurler form is characterized by skeletal abnormalities, hepatosplenomegaly and severe mental retardation" but is not specific to this patient.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.46_57del (p.Ser16_Ala19del); in the paper it is listed as c.134del12 (old nomenclature)
Variant2ClinVarID: 92643
Variant2CAID: CA220509
AdditionalVariants: N/A
ParentalGenotype: Parental testing conducted, each parent was shown to carry one of the sequence changes found in their affected child.
PreviouslyPublished N/A
R619X
Case#: Family 8, UK
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: The paper states that "Hurler form is characterized by skeletal abnormalities, hepatosplenomegaly and severe mental retardation" but is not specific to this patient.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1855C>T (p.R619X)
Variant2ClinVarID: 280976
Variant2CAID: CA2802455
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Patient 1, male, 6.9 months (age at HSCT), 4.2 months (age at ERT)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Autoimmune hemolysis (HP:0001890)
CaseHPOFreeText: Rhinovirus pneumonitis
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.22 (at diagnosis), 55.5 (post HSCT) Units not provided.
CaseUrineGAGs: N/A
CaseERT: Yes - 83 days duration
CaseBMT: Yes - MUD (matched unrelated donor) with stem cells sourcing from the CB (cord blood)
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
patient
Case#: Patient with Hurler Syndrome. No clinical information provided.
DiseaseAssertion: MPS-IH
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Effect of small molecule eRF3 degraders on premature termination codon readthrough
PMID: 33764477
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
patient
Case#: Female, 6 months old (age of onset), 1 year old (age at report), Mauritanian descent, weight of 7.94 kg (5%), length of 75 cm (just below 50%), occipitofrontal circumference was 47 cm (95%).
DiseaseAssertion: MPS1-H
FamilyInfo: Born from healthy first cousins
CasePresentingHPOs: Eczema, mild coarse facial features, frontal bossing, depressed nasal bridge, flared nostrils, retrognathia, truncal hypotonia, Mongolian blue spot, dilated cardiomyopathy, hip dislocation (HP:0000964, HP:0000256, HP:0002007, HP:0005280, HP:0000454, HP:0000278, HP:0008936, HP:0011369, HP:0001644, HP:0002827)
CaseHPOFreeText: N/A
CaseNotHPOs: Hepatosplenomegaly (HP:0001433)
CaseNotHPOFreeText: Hands and feet were normal. A neuro-exam revealed intact cranial nerves and normal power and deep tendon reflexes were normal. Cranial computed tomography (CT)-scan and abdominal ultrasound were normal.
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: Both mother and father received WES and are confirmed heterozygous carriers of c.1598C>G (p.P533R)
PreviouslyPublished N/A
Scheie
Case#: 0.7% residual activity at 37 °C
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 1.9 ± 0.7 nmol/mg/h IDUA activity at 37 °C
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1148G>A (p.R383H)
Variant1ClinVarID: 558189
Variant1CAID: CA2802205
Variant2: c.1148G>A (p.R383H)
ClinVarID: 558189
Variant2CAID: CA2802205
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Mutation analysis and clinical characterization of Iranianpatients with mucopolysaccharidosis type I
PMID: 31386236 Gene: IDUA Disease: MPS1 Inheritance: Autosomal recessive
5
Case#: Patient 5, born in 1991 (paper published in 2017), 10 months (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding, retinopathy (HP:0007957, HP:0000488)
CaseHPOFreeText: N/A
CaseNotHPOs: Cataract (HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 21.6 ng/mol (40.9 weight matched enzyme reference assay)
CaseUrineGAGs: 0.79 DS/CS
CaseERT: No
CaseBMT: Yes, Sib
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
8
Case#: Patient 8, born in 1994 (paper published in 2017), 9 months (age at first treatment), 2 years 3 months (age at last treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding, retinopathy, cataract (HP:0007957, HP:0000488, HP:0000518)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 7.14 ng/mol (56.53 weight matched enzyme reference assay)
CaseUrineGAGs: 1.24 DS/CS
CaseERT: No
CaseBMT: Yes, Sib
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
9
Case#: Patient 9, born in 2008 (paper published in 2017), 8 months (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding (HP:0007957)
CaseHPOFreeText: N/A
CaseNotHPOs: Retinopathy, cataract (HP:0000488, HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 47 ng/mol (32 weight matched enzyme reference assay)
CaseUrineGAGs: 0.34 DS/CS
CaseERT: Yes
CaseBMT: Yes, Cord
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.208C>T (p.Q70X)
Variant2ClinVarID: 11909
Variant2CAID: CA204563
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
3
Case#: Patient 3, born in 2005 (paper published in 2017), 2 years and 7 months (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding (HP:0007957)
CaseHPOFreeText: N/A
CaseNotHPOs: Retinopathy, cataract (HP:0000488, HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 86 ng/mol (60 weight matched enzyme reference assay)
CaseUrineGAGs: 0.43 DS/CS
CaseERT: Yes
CaseBMT: Yes, Sib
Variant1: c.17_24CCCGCGCC (Found to be c.17_24dup) (p.Ala9ProfsTer?)
Variant1ClinVarID: N/A
Variant1CAID: CA645372294
Variant2: c.1871A>T (p.Asp624Val)
Variant2ClinVarID: N/A
Variant2CAID: CA355965955
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
11
Case#: Patient 11, born in 2003 (paper published in 2017), 1 year (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding (HP:0007957)
CaseHPOFreeText: N/A
CaseNotHPOs: Retinopathy, cataract (HP:0000488, HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 71.98 ng/mol (10.86 weight matched enzyme reference assay)
CaseUrineGAGs: 0.38 DS/CS
CaseERT: Yes
CaseBMT: Yes, Cord
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.208C>T (p.Q70X)
Variant2ClinVarID: 11909
Variant2CAID: CA204563
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
5/m
Case#: Patient 5, male, 17.5 months (age at diagnosis), 21.5 months (age at HSCT), 5 MRI + neuropsychological observations over the course of 10 years.
DiseaseAssertion: MPS-1H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 37.2 nmol/h/mg (Normal values: 11-43 nmol/h/mg)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: Yes
Variant1: c.1166_1171dup (p.A389_M390dup)
Variant1ClinVarID: N/A
Variant1CAID: CA2586965963
Variant2: c.1166_1171dup (p.A389_M390dup)
Variant2ClinVarID: N/A
Variant2CAID: CA2586965963
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Pt 7, age is 13 months (proband can be found in Table 1)
DiseaseAssertion: Hurler syndrome, mucopolysaccharidosis type IH, MPS IH, MPS type I
FamilyInfo: No family information provided
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: In methods it is stated that an IDUA activity assay was conducted on cartilaginous pellets generated from patient-derived bone marrow stromal cells at 5 weeks. However, results of the IDUA activity assays are not stated.
CaseUrineGAGs: "Significantly higher levels of GAGs in MPS IH compared with HD pellets at.1 week of chondrogenic differentiation, thus indicating that GAG accumulation in MPS IH can be seen during cell condensation and early differentiation stages." Total GAG content for each sample in ug GAG/ug DNA shown in Figure 4 graphs.
CaseERT: Don't know
CaseBMT: Don't know
Variant1: p.Q70X
Variant1ClinVarID:
Variant1CAID: PA3044620172
Variant2: c.398_403del6
Variant2ClinVarID: 863830
Variant2CAID: CA2801912
AdditionalVariants: No additional variants mentioned
ParentalGenotype: No parental information provided
PreviouslyPublished: No mention of being previously published
Case#: Pt 4, age is 12 months (proband can be found in Table 1)
DiseaseAssertion: Hurler syndrome, mucopolysaccharidosis type IH, MPS IH, MPS type I
FamilyInfo: No family information provided
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: In methods it is stated that an IDUA activity assay was conducted on cartilaginous pellets generated from patient-derived bone marrow stromal cells at 5 weeks. However, results of the IDUA activity assays are not stated.
CaseUrineGAGs: "Significantly higher levels of GAGs in MPS IH compared with HD pellets at.1 week of chondrogenic differentiation, thus indicating that GAG accumulation in MPS IH can be seen during cell condensation and early differentiation stages." Total GAG content for each sample in ug GAG/ug DNA shown in Figure 4 graphs.
CaseERT: Don't know
CaseBMT: Don't know
Variant1: p.P496R
Variant1ClinVarID: 496861
Variant1CAID: CA2802275
Variant2: p.P496R
Variant2ClinVarID: 496861
Variant2CAID: CA2802275
AdditionalVariants: No additional variants mentioned
ParentalGenotype: No parental information provided
PreviouslyPublished: No mention of previously being published
13
Case#: 13, Male, 0.8 years (diagnosed), 1.6 years (report), 7.2 kg (weight), 71 cm (height), Iranian
DiseaseAssertion: Scheie Syndrome
FamilyInfo: Parents are not consanguineous
CasePresentingHPOs: HP:0001249, HP:0001999, HP:0100790 (Mental Retardation, Facial Dysmorphic Features, Hernia)
CaseHPOFreeText: HM/HSM, Chronic Rhinorrhea
CaseNotHPOs: HP:0000943, HP:0001387, HP:0000365, HP:0007957, HP:0000238 (Multiple Dysostosis, Joint Stiffness, Deafness, Corneal Opacity, Hydrocephalus)
CaseNotHPOFreeText: Cardiac Manifestations
CaseEnzymeAssay: IDUA activity 0.75 (μmol/spot.20h)
CaseUrineGAGs: Quantitative urinary GAG 7.4 (mg/gCr)
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Sanger Sequencing
Variant1: p.S157P
Variant2: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
21
Case#: 21, Female, 0.8 years (diagnosed), 2.8 years (report), 7.5 kg (weight), 80 cm (height), Iranian
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Parents are consanguineous
CasePresentingHPOs:HP:0001249, HP:0001999, HP:0000943, HP:0001387, HP:0100790, HP:0000365, HP:0007957, HP:0000238 (Mental Retardation, Facial Dysmorphic Features, Multiple Dysostosis, Joint Stiffness, Hernia, Deafness, Corneal Capacity, Hydrocephalus)
CaseHPOFreeText: HM/HSM, Chronic Rhinorrhea, Cardiac Manifestations (mitral stenosis)
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.98 (μmol/spot.20h)
CaseUrineGAGs: Quantitative urinary GAG 10.5 (mg/gCr)
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Sanger Sequencing
Variant1: Not Provided
Variant2: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
7
Case#: 7, Female, 0.7 years (diagnosed), 12.9 years (report), 14.2 kg (weight), 97 cm (height), Iranian
DiseaseAssertion: Hurler-Scheie Syndrome
FamilyInfo: Parents are consanguineous
CasePresentingHPOs: HP:0001249, HP:0001999, HP:0000943, HP:0001387, HP:0100790, HP:0000365, HP:0000238 (Mental Retardation, Facial Dysmorphic Features, Multiple Dysostosis, Joint Stiffness, Hernia, Deafness, Hydrocephalus)
CaseHPOFreeText: HM/HSM, Chronic Rhinorrhea
CaseNotHPOs: HP:0007957 (Corneal Capacity)
CaseNotHPOFreeText: Cardiac Manifestations
CaseEnzymeAssay: IDUA activity 0.86 (μmol/spot.20h)
CaseUrineGAGs: Quantitative urinary GAG 10.11 (mg/gCr)
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Sanger Sequencing
Variant1: p.G84R
Variant2: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
3.3.1. Severe patients There were 115 individual genotypes represented in the 380 patients with a severe phenotype and two reported alleles; 31 genotypes were recurrent and 84 genotypes unique (Table 3). The most common genotypes in severe patients were W402X/W402X (109/380; 28.7%), W402X/Q70X (61/380; 16.1%) and Q70X/Q70X (24/380; 6.3%). In total, these two nonsense variants defined the genotypes of 51% (194/380) of severe patients. Of severe patients, 67.6% (257/380) were either homozygous or compound heterozygous for two variants predicted to severely disrupt gene transcription or translation (eg, nonsense variants, frameshifts, consensus splice site disruption or initiator codon variants). No clinically diagnosed attenuated patients were homozygous or compound heterozygous for such variants. Of the remaining 123 severe patients, 76 comprised 19 recurrent genotypes (Table 3) with the remaining 47 patients (12.6%) having unique genotypes (listed in Table S1). Thirty‐seven of the 84 unique genotypes identified in severe patients were compound heterozygous with two severe variants (as defined above) and were comprised of 34 separate severe variants (listed in Table S1). There were nine missense recurrent variants and one intronic recurrent variant that were exclusively seen in severe patients (Table 5A).
Case#: Severe MPS1 patients
DiseaseAssertion: Severe MPS I
FamilyInfo: n/a, "neither the laboratory method used to determine the sequence variants nor whether parental testing confirmed the inheritance or phase of the variants is captured by the Registry"
CasePresentingHPOs:
CaseHPOFreeText: "All patients enrolled in the Registry have confirmation of MPS I diagnosis by either mutation analysis or measurement of IDUA levels."
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting: n/a
GenotypingMethod: n/a
PreviouslyPublished: possible since this is a multinational registry
Variant: c.1728-1G>C/Q70X
ClinVar: 556064
CAID: CA355965306
SupplementalData: Table S1 has the genotypes listed
A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
PMID: 24053568
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
10
Case#: Patient 10 (see Table 1), 8 years old - deceased (age at report), 5 years old (age at onset), female, height of 107 cm, weight of 19 kg, located at Nfidha: Industrial region
DiseaseAssertion: MPS1 - severe
FamilyInfo: Parents were 1st cousins (see Table 2), aged 42 yrs (M) and 50 yrs (F).
CasePresentingHPOs: HP:0004322, HP:0001999, HP:0010864, HP:0002240 (Short stature, facial dysmorphia, severe intellectual disability, hepatomegaly)
CaseHPOFreeText: Pulmonary and cardiac deficiency.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA:256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA:256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
11
Case#: Patient 11 (see Table 1), 6 years old (age at report), 1 year old (age at onset), female, height of 120 cm, weight of 20 kg, located in Tunis: Industrial region
DiseaseAssertion: MPS1 - mild
FamilyInfo: Parents were 2nd cousins (see Table 2), aged 37 yrs (M) and 44 yrs (F).
CasePresentingHPOs: HP:0004322, HP:0001999, HP:0030799, HP:0001537 (Short stature, facial dysmorphia, scaphocephaly, umbilical hernia)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.09 μKat/kg
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1733T>A (p.L578Q)
Variant1ClinVarID: N/A
Variant1CAID: CA355965319
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
PKMPS1P3
Case#: PKMPS1P3, 6 months old (age at presentation), female, Pakastani, born full term through C-section
DiseaseAssertion: MPS-I
FamilyInfo: Born to consanguineous parents
CasePresentingHPOs: Abdominal distension (at 6 months), difficulty breathing, macrocephaly, coarse facial features, hernia, cardiomyopathy, recurrent respiratory infections, recurrent ear infections, joint contractures (HP:0003270, HP:0002094, HP:0000256, HP:0000256, HP:0100790, HP:0001638, HP:0002788, HP:0410018, HP:0100790)
CaseHPOFreeText: Abnormal spine position. The liver span was 10 cm, having soft to firm consistency. The spleen was palpable and soft. Bone pains. X-ray of the skull showed reverse J-shaped sella sutural diastasis, and the X-ray of the hand showed proximal tapering Q metatarsal. Thick broad arc-shaped ribs, thick skull calvarium, with apparently enlarged cardiac size was observed in the chest X-ray.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.314G>A (p.R105Q)
Variant1ClinVarID: 92641
Variant1CAID: CA145881
Variant2: c.314G>A (p.R105Q)
Variant2ClinVarID: 92641
Variant2CAID: CA145881
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
PKMPS1P1
Case#: PKMPS1P1, 4 years old (age at presentation), female
DiseaseAssertion: MPS-I
FamilyInfo: Born to a consanguineous couple
CasePresentingHPOs: Joint stiffness, coarse facial features, dysostosis multiplex, hernia (HP:0001387, HP:0000256, HP:0000943, HP:0100790)
CaseHPOFreeText: Difficulty walking, limitation in the range of movements of joints. Failure to gain height and weight.
CaseNotHPOs: Developmental delay (HP:0001263)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
1
Case#: No additional case information provided.
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.653T>C (p.L218P)
Variant1ClinVarID: 222995
Variant1CAID: CA356986
Variant2: c.653T>C (p.L218P)
Variant2ClinVarID: 222995
Variant2CAID: CA356986
AdditionalVariants: In the paper an additional variant is listed on the same allele as "G387 + 6c->t". It seems that the current nomenclature for this variant is "c.299+6C>T". This variant is classified as benign by the LD VCEP.
ParentalGenotype: N/A
PreviouslyPublished N/A
18-year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I
PMID: 36333985
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
10
Case#:Subject 10 : 23 years male, age of onset unknown DiseaseAssertion:MPS1 FamilyInfo:NA CasePresentingHPOs:NA CaseHPOFreeText:recieved Zinc-finger nuclease(ZFN) based in vivo genome editing as part of Study SB-318-1502, one time IV administration.Monitored by Iduronidase enzyme levels and Urine Heparan sulfate levels durinng enzyme withdrawal. ERt recommenced later. CaseNotHPOs:NA CaseNotHPOFreeText:NA CaseEnzymeAssay:Iduronidase 1.20 nmol/mL/h (normal: 6–71.4 nmol/h/mg) CaseUrineGAGs: CaseERT: <br /> CaseBMT:NA Variant1: IDUA c.386-2A>G Variant1ClinVarID: 222994 Variant1CAID: CA356991 Variant2: IDUA c.1898C>T Variant2ClinVarID: 556406 Variant2CAID: AdditionalVariants:NA ParentalGenotype:NA PreviouslyPublishedNA
Case#: Patient is from The Netherlands
DiseaseAssertion: MPSI-H
FamilyInfo: Patient has consanguinity between parents.
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.653T>C (p.L218P)
Variant1ClinVarID: 222995
Variant1CAID: CA356986
Variant2: c.653T>C (p.L218P)
Variant2ClinVarID: 222995
Variant2CAID: CA356986
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
MPS I_Case 01
Case#: MPS I_Case 01, male newborn
DiseaseAssertion: MPS type I, MPS I, MPS-I, attenuated MPS I
FamilyInfo: MPS I_Case 01 and MPS I_Case 05 are siblings
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText: This proband is believed to be an affected MPS-patient however, the proband did not have any obvious clinical symptoms to date (up to two years of age). The paper states that this attenuated MPS I case will need a long term follow up.
CaseEnzymeAssay: Proband identified by newborn screening. alpha-L-iduronidase activity in dried blood spot sample is 0.42 umole/L/Hr; this is below the study’s DBS enzyme activity cutoff value of 3 umol/L/h
CaseUrineGAGs: Urine DMB GAG ratio is 107 mg/mmol creatinine. 10.9 ug/ml dermatan sulfate in urine (<0.41 ug/ml is the reference cutoff for dermatan sulfate in this study). 2.67 ug/ml heparan sulfate in urine (<0.8 ug/ml is the reference cutoff for heparan sulfate in this study). 7/75 ug/ml keratan sulfate in urine.
CaseERT: Don’t know (would assume no since the proband is a newborn)
CaseBMT: Don’t know (would assume no since the proband is a new born)
Variant1: c.300–3C>G
Variant1ClinVarID: 551563
Variant1CAID: CA549265042
Variant2: c.1874A>C, p.Y625S
Variant2ClinVarID: 2910181
Variant2CAID: CA355965961
AdditionalVariants: No additional variants are mentioned
ParentalGenotype: No parental testing results are available
PreviouslyPublished No statement from the author indicating the proband is previously published. Since this is a newborn study, I strongly believe this is the proband’s first time being published.
310.423 (5.1)7.9DS 2.7heterozygous PD: c.235G>A; p.A79TNot examined at UNC-CHHS 2.5heterozygous PD: c.296C>T; p.T99Iheterozygous PD: c.667G>A; p.D223N
Case#:Patient Sample unique ID 31, Infant screened positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)
DiseaseAssertion:None
FamilyInfo:None
CasePresentingHPOs:None
CaseHPOFreeText:None
CaseNotHPOs:None
CaseNotHPOFreeText: Normal examination at follow up after screening positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)
CaseEnzymeAssay: IDUA activity 0.423 (7.9) umol/L/h (%DMA) during new born screening through dried blood spot (plasma) and 7.9 pmol/punch/h Confirmatory IDUA enzyme
CaseUrineGAGs: DS 2.7 g/mol creatinine and HS 2.5 g/mol creatinine (Normal)
CaseERT:No
CaseBMT:No
Variant1:homozygous PD: c.235G>A; p.A79T (Normal examination)
Variant1ClinVarID:41682
Variant1CAID: CA000358
Variant2: homozygous PD: c.296C>T; p.T99I
Variant2ClinVarID:53610
Variant2CAID:CA326991
AdditionalVariants:None
ParentalGenotype:None provided
PreviouslyPublished:N/A
580.413 (5.3)8.7N/A§heterozygous PD: c.235G>A; p.A79TNormal examinationheterozygous PD: c.296C>T; p.T99Iheterozygous PD: c.667G>A; p.D223N
Case#:Patient Sample unique ID 58, Infant screened positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)
DiseaseAssertion:None
FamilyInfo:None
CasePresentingHPOs:None
CaseHPOFreeText:None
CaseNotHPOs:None
CaseNotHPOFreeText: Normal examination at follow up after screening positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)
CaseEnzymeAssay: IDUA activity 0.413 (8.7) umol/L/h (%DMA) during new born screening through dried blood spot (plasma) and 8.7 pmol/punch/h Confirmatory IDUA enzyme
CaseUrineGAGs: N/A (Family refused to collect additional urine specimen.)
CaseERT:No
CaseBMT:No
Variant1:homozygous PD: c.235G>A; p.A79T (Normal examination)
Variant1ClinVarID:41682
Variant1CAID: CA000358
Variant2: homozygous PD: c.296C>T; p.T99I
Variant2ClinVarID:53610
Variant2CAID:CA326991
AdditionalVariants: heterozygous PD: c.667G>A; p.D223N (ClinVarID: 2220838, CAID: CA363422841)
ParentalGenotype:None provided
PreviouslyPublished:N/A
1/m
Case#: 1, Male, Han Chinese
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0001249, HP:0007957, HP:0001433 (Mental Retardation (severe), Corneal Clouding, Hepatosplenomegaly)
CaseHPOFreeText: Skeletal Deformities
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0 Leukocyte IDUA activity (nmol/h/mg protein) (isolated leukocytes in the latter)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Using the artificial substrate 4-methyl-umbelliferyl α-L-iduronide (Sigma)
Variant1: c.1190-1G>A
Variant1ClinVarID: 1204494
Variant1CAID: CA355963511
Variant2: Not Identified
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
8/m
Case#: 8, Male, Han Chinese
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0001249, HP:0007957, HP:0001433 (Mental Retardation (severe), Corneal Clouding, Hepatosplenomegaly)
CaseHPOFreeText: Skeletal Deformities
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0 Leukocyte IDUA activity (nmol/h/mg protein) (isolated leukocytes in the latter)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Using the artificial substrate 4-methyl-umbelliferyl α-L-iduronide (Sigma)
Variant1: c.792+1G>T
Variant1ClinVarID: N/A
Variant1CAID: CA355962278
Variant2: Not identified
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome
PMID: 25116402
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Whole paternal uniparental disomy of chromosome 4 with a novel homozygous IDUA splicing variant, c.159‐9T>A, in a Chinese patient with mucopolysaccharidosis type I
PMID: 39132856
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Case#: Patient 2, 12 years old, Iranian
DiseaseAssertion: MPS1-S (Attenuated)
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.3 µmol/g.h (Normal ranges: 10-50 µmol/g.h)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.401G>T (p.G134V)
Variant1ClinVarID: N/A
Variant1CAID: CA355961317
Variant2: c.401G>T (p.G134V)
Variant2ClinVarID: N/A
Variant2CAID: CA355961317
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Differences in MPS I and MPS II Disease Manifestations
PMID: 34360653
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Case#: Patient 2, Turkish
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.192C>A (p.Y64X)
Variant1ClinVarID: 11914
Variant1CAID: CA256113
Variant2: c.979G>C (p.A327P); Table states c.1067G>C instead of c.979G>C. This variant is not in ClinVar or has a CAID. Assuming there is a typo and this is c.979G>C
Variant2ClinVarID: 167190
Variant2CAID: CA234128
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Identification of a novel compound heterozygous IDUA mutation underlies Mucopolysaccharidoses type I in a Chinese pedigree
PMID: 31758674
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Mutation c.1190-1delG/N in intron 8 and c.1708G>C/N in exon 12 not reported in the IDUA gene developed a clinical phenotype of Scheie syndrome
PMID: 25558755
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
infant’s
Case#: Infant (Pregnancy was terminated at 35 gestational weeks due to severe MPS I diagnosis, weight of 3140 g (94th percentile), length of 48 cm (80th percentile), occipitofrontal circumference of 34 cm (83rd percentile).
DiseaseAssertion: MPS1
FamilyInfo: Proband 1's mother and father were not consanguineous, their phenotype was normal, and they had no significant personal or family histories. Mother had previously had given birth to a healthy infant.
CasePresentingHPOs: Single umbilical artery, hepatosplenomegaly, hepatomegaly, coarse facial features, broad nasal tip, micrognathia, thin upper lip vermilion, hypertelorism, plagiocephaly (HP:0001195, HP:0001433, HP:0002240, HP:0000280, HP:0000455, HP:0000347, HP:0000219, HP:0000316, HP:0001357)
CaseHPOFreeText: Dysmorphic features (including a long and broad philtrum), a few echogenic spots in the liver, spleen, peritoneum, and thymus, hepatic overhang of 4 cm, microretrognatism, full and drooping cheeks, large, badly hemmed ears with bulky lobes, bulging eyes, marked suborbital folds, and micro vacuolized appearance of Hofbauer cells.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Deficiency in α-L-iduronidase activity. Measure value was 0.3 µkat/kg with a laboratory control of 33.8 µkat/kg.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.590G>A (p.G197D)
Variant1ClinVarID: 554670
Variant1CAID: CA91167598
Variant2: c.1139dup (p.L381Afs*18)
Variant2ClinVarID: 3340107
Variant2CAID: CA3046517234
AdditionalVariants: N/A
ParentalGenotype: c.590G>A (inherited from the mother), c.1139dup (inherited from the father)
PreviouslyPublished N/A
patients
Case#: Patient 1, 1-year old at the start of ERT
DiseaseAssertion: MPS1-H - confirmed diagnosis of MPS 1 by enzymatic and mutation analysis
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: Urine GAGs are displayed in a figure and show the level at the start of ERT to 24-months later. At the start, urine GAGs appear to be slightly above 100 mg/mmol creatinine. After 24-months they decreased to be slightly below 50 mg/mmol creatinine. Normal values for >2-year olds are 8-20 mg/mmol creatinine.
CaseERT: Yes - started at 1-year old and was given once every week
CaseBMT: No
Variant1: c.494-1G>A (in the paper, the variant is labeled as IVS4-1G>A)
Variant1ClinVarID: 557942
Variant1CAID: CA355961634
Variant2: c.494-1G>A (in the paper, the variant is labeled as IVS4-1G>A)
Variant2ClinVarID: 557942
Variant2CAID: CA355961634
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
35 Q
Case: Patient 35, Family Q (Table 1.), F/42, Afro-Caribbean
DiseaseAssertion: VWD2A (IIE)
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs:
CaseHPOFreeRext: BAT = 4, FVIII:C (IU/dL) = 24, VWF:Ag (IU/dL) = 25, VWF:Act (IU/dL) = 14
CaseNOTHPOs:
CaseNOTHPOFreeText: Blood group O+
CasePreviousTesting:
GenotypingMethod: All samples were analyzed by captured-based high throughput sequencing which was performed with a custom-design of the VWF gene provided by Twist BioScience (San Francisco, USA). It comprised all 52 exons, intronic flanking regions, promoter and 3’UTR region of the VWF gene. Libraries were prepared by using the Twist NGS target enrichment solution (Twist BioScience) according to the manufacturer protocol. Samples were analyzed on a NovaSeq 6000 sequencer (Illumina) with a median read depth of 2500X by using the 300-cycle S1 NovaSeq 6000seq reagent kit with 150-bp paired-end reads. The raw data were analyzed with Mutect21 and Vardict2 tools. The inhouse NGSreport software (CHU Lille) was used for data visualization, sequences check and conservation of variants with high quality metrics. In some cases, patients genomic DNA was screened for sequence variations (large deletions, insertions and duplications) by Multiplex Ligation-dependent Probe Amplification (MCR Holland).
PreviouslyPublished: NA
Gene: VWF
Variant: c.1530G > A, p.(Val510 =) p.
HGVS: NM_000552.5:c.1530G>A (p.Val510=)
ClinVarID:
CAID: CA6403368
gnomAD: MAF of 0.00002198 (2/91004 alleles) in South Asian population https://gnomad.broadinstitute.org/variant/chr12-6062957-C-T?dataset=gnomad_r4
Variant: c.1892C > T, p.(Ala631Val)
HGVS: NM_000552.5:c.1892C>T (p.Ala631Val)
ClinVarID: 422844
CAID: CA6403245
gnomAD: MAF of 0.001908 (137/71810 alleles) in African/African American population https://gnomad.broadinstitute.org/variant/chr12-6056910-G-A?dataset=gnomad_r4
Variant: c.2220G > A, p.(Met740Ile)
HGVS: NM_000552.5:c.2220G>A (p.Met740Ile)
ClinVarID: 100206
CAID: CA201316
gnomAD: MAF of 0.1816 (13626/75022 alleles) in African/African American population https://gnomad.broadinstitute.org/variant/chr12-6046784-C-T?dataset=gnomad_r4
Variant: c.2451T > A, p.(His817Gln)
HGVS: NM_000552.5:c.2451T>A (p.His817Gln)
ClinVarID: 100224
CAID: CA228345
gnomAD: MAF of 0.1150 (8626/75016 alleles) in African/African American population https://gnomad.broadinstitute.org/variant/chr12-6036483-A-T?dataset=gnomad_r4
Variant: c.3445T > C, p.(Cys1149Arg)
HGVS: NM_000552.5:c.3445T>C (p.Cys1149Arg)
ClinVarID: 309
CAID: CA228410
gnomAD: MAF of 0.000003160 (1/316464 alleles) in European (non-Finnish) population https://gnomad.broadinstitute.org/variant/chr12-6022833-A-G?dataset=gnomad_r4
Variant: c.4414G > C p.(Asp1472His)
HGVS: NM_000552.5:c.4414G>C (p.Asp1472His)
ClinVarID: 256679
CAID: CA6402534
gnomAD: MAF of 0.5076 (38011/74882 alleles) in African/African American population https://gnomad.broadinstitute.org/variant/chr12-6019004-C-G?dataset=gnomad_r4
Variant: c.6554G > A, p.(Arg2185Gln)
HGVS: NM_000552.5:c.6554G>A (p.Arg2185Gln)
ClinVarID: 100443
CAID: CA228748
gnomAD: MAF of 0.1927 (14427/74878 alleles) in African/African American population https://gnomad.broadinstitute.org/variant/chr12-5993906-C-T?dataset=gnomad_r4
Variant: c.8174A > G, p.(Asn2725Ser)
HGVS: NM_000552.5:c.8174A>G (p.Asn2725Ser)
ClinVarID:
CAID: CA232258860
gnomAD: MAF of 0.00004456 (2/44880 alleles) in East Asian population https://gnomad.broadinstitute.org/variant/chr12-5949865-T-C?dataset=gnomad_r4
44 U
Case: Patient 44, Family U (Table 1.), M/15, Afro-Caribbean
DiseaseAssertion: VWD2M
FamilyInfo: Patient 43 (M/10, Afro-Caribbean), Patient 46 (M/47, Afro-Caribbean, Patient 47(M/78, Afro-Caribbean) and Patient 48 (M/43, Afro Caribbean) also from Family U. (Table 1.)
ParentalGenotype(s): NA
CasePresentingHPOs:
CaseHPOFreeRext: BAT = 4, FVIII:C (IU/dL) = 48, VWF:Ag (IU/dL) = 25, VWF:Act (IU/dL) = 7
CaseNOTHPOs:
CaseNOTHPOFreeText: Blood group B+
CasePreviousTesting:
GenotypingMethod: All samples were analyzed by captured-based high throughput sequencing which was performed with a custom-design of the VWF gene provided by Twist BioScience (San Francisco, USA). It comprised all 52 exons, intronic flanking regions, promoter and 3’UTR region of the VWF gene. Libraries were prepared by using the Twist NGS target enrichment solution (Twist BioScience) according to the manufacturer protocol. Samples were analyzed on a NovaSeq 6000 sequencer (Illumina) with a median read depth of 2500X by using the 300-cycle S1 NovaSeq 6000seq reagent kit with 150-bp paired-end reads. The raw data were analyzed with Mutect21 and Vardict2 tools. The inhouse NGSreport software (CHU Lille) was used for data visualization, sequences check and conservation of variants with high quality metrics. In some cases, patients genomic DNA was screened for sequence variations (large deletions, insertions and duplications) by Multiplex Ligation-dependent Probe Amplification (MCR Holland).
PreviouslyPublished: NA
Gene: VWF
Variant: c.3943C > T p.(Arg1315Cys)
HGVS: NM_000552.5:c.3943C>T (p.Arg1315Cys)
ClinVarID: 100310
CAID: CA228502
gnomAD: MAF of 8.476e-7 (1/ 1179850 alleles) in European population https://gnomad.broadinstitute.org/variant/chr12-6019161-A-C?dataset=gnomad_r4
42 T
Case: Patient 42, Family T (Table 1.), F/60, Afro-Caribbean
DiseaseAssertion: VWD2A (IIA)
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs:
CaseHPOFreeRext: BAT = 8, FVIII:C (IU/dL) = 20, VWF:Ag (IU/dL) = 35, VWF:Act (IU/dL) = 6
CaseNOTHPOs:
CaseNOTHPOFreeText: Blood group O+
CasePreviousTesting:
GenotypingMethod: All samples were analyzed by captured-based high throughput sequencing which was performed with a custom-design of the VWF gene provided by Twist BioScience (San Francisco, USA). It comprised all 52 exons, intronic flanking regions, promoter and 3’UTR region of the VWF gene. Libraries were prepared by using the Twist NGS target enrichment solution (Twist BioScience) according to the manufacturer protocol. Samples were analyzed on a NovaSeq 6000 sequencer (Illumina) with a median read depth of 2500X by using the 300-cycle S1 NovaSeq 6000seq reagent kit with 150-bp paired-end reads. The raw data were analyzed with Mutect21 and Vardict2 tools. The inhouse NGSreport software (CHU Lille) was used for data visualization, sequences check and conservation of variants with high quality metrics. In some cases, patients genomic DNA was screened for sequence variations (large deletions, insertions and duplications) by Multiplex Ligation-dependent Probe Amplification (MCR Holland).
PreviouslyPublished: NA
Gene: VWF
Variant: c.4257T > G p.(His1419Gln)
HGVS: NM_000552.5:c.4257T>G (p.His1419Gln)
ClinVarID: 2691691
CAID: CA6402565
gnomAD: MAF of 0.0003166 (19/60010 alleles) in Admixed American population https://gnomad.broadinstitute.org/variant/chr12-6019161-A-C?dataset=gnomad_r4
Variant: c.4414G > C p.(Asp1472His)
HGVS: NM_000552.5:c.4414G>C (p.Asp1472His)
ClinVarID: 256679
CAID: CA6402534
gnomAD: MAF of 0.5076 (38011/74882 alleles) in African/African American population https://gnomad.broadinstitute.org/variant/chr12-6019004-C-G?dataset=gnomad_r4
Variant: c.4517C > T p.(Ser1506Leu)
HGVS: NM_000552.5:c.4517C>T (p.Ser1506Leu)
ClinVarID: 100369
CAID: CA228615
gnomAD: MAF of 0.0001735 (10/57628 alleles) in Admixed American population https://gnomad.broadinstitute.org/variant/chr12-6018901-G-A?dataset=gnomad_r4
51 Y
Case: Patient 51, Family Y (Table 1.), F/33, Afro-Caribbean
DiseaseAssertion: VWD1
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs:
CaseHPOFreeRext: BAT = 5, FVIII:C (IU/dL) = NA, VWF:Ag (IU/dL) = 30, VWF:Act (IU/dL) = 31
CaseNOTHPOs:
CaseNOTHPOFreeText: Blood group O+
CasePreviousTesting:
GenotypingMethod: All samples were analyzed by captured-based high throughput sequencing which was performed with a custom-design of the VWF gene provided by Twist BioScience (San Francisco, USA). It comprised all 52 exons, intronic flanking regions, promoter and 3’UTR region of the VWF gene. Libraries were prepared by using the Twist NGS target enrichment solution (Twist BioScience) according to the manufacturer protocol. Samples were analyzed on a NovaSeq 6000 sequencer (Illumina) with a median read depth of 2500X by using the 300-cycle S1 NovaSeq 6000seq reagent kit with 150-bp paired-end reads. The raw data were analyzed with Mutect21 and Vardict2 tools. The inhouse NGSreport software (CHU Lille) was used for data visualization, sequences check and conservation of variants with high quality metrics. In some cases, patients genomic DNA was screened for sequence variations (large deletions, insertions and duplications) by Multiplex Ligation-dependent Probe Amplification (MCR Holland).
PreviouslyPublished: NA
Gene: VWF
Variant: c.4751A > G, p.(Tyr1584Cys)
HGVS: NM_000552.5:c.4751A>G (p.Tyr1584Cys)
ClinVarID: 310
CAID: CA114162
gnomAD: MAF of 0.004105 (483/1179782 alleles) in European/Non-Finnish population https://gnomad.broadinstitute.org/variant/chr12-6018667-T-C?dataset=gnomad_r4
III-3,
Case: Patient III-3 (proband's granduncle; father of IV-2 and IV-3) DiseaseAssertion: Type 2A VWD, based on low plasma VWF:Ag and activity and lack of plasma HMW VWF multimers (diagnosis explicitly extended to this patient along with proband and IV-2, IV-3, IV-4). FamilyInfo: Granduncle of proband V-2; father of IV-2 and IV-3 (both also affected); part of 5-affected-member pedigree (Fig. 1). ParentalGenotype(s): NA — his own parents' (generation II) genotype status not reported. CasePresentingHPOs: HP:0012147 (Reduced quantity of VWF; VWF:Ag 21.6 U/dL), HP:0030129 (Impaired VWF:RCo; VWF:Rco 5.0 U/dL), HP:0030132 (Absence of large VWF multimers — plasma), HP:0003645 (Prolonged partial thromboplastin time; APTT 45.5 sec) CaseHPOFreeText: Described only generically as having "abnormal bleedings" / "similar clinical symptoms" to the proband — no itemized bleeding symptoms given for this individual specifically. FVIII:C 28.0 U/dL (nv 50-150). RIPA not tested (N/A). TT 16.7 sec and PT 14.0 sec both within normal range. CaseNOTHPOs: NA CaseNOTHPOFreeText: Platelet-associated VWF multimers normal (HMW multimers present) per the group finding covering this patient. CasePreviousTesting: Targeted confirmation of the familial VWF variant; not genome-wide. GenotypingMethod: Sanger sequencing/allele-specific analysis, same platform as proband. PreviouslyPublished: NA Gene: VWF Variant: Same novel heterozygous in-frame 6-bp deletion, exon 28, ΔD1529V1530 (VWF A2 domain) HGVS: c.4585_4590del (p.Asp1529_Val1530del) ClinVarID: NA CAID: NA gnomAD: NA
The proband was a 9-year-old boy, whose family pedigree is shown in Fig. 1. He suffered from frequent bruise, epistaxis, prolonged bleedings from small wounds, and delayed wound healing.
Case: Patient V-2, Male, 9 years old (proband) DiseaseAssertion: Type 2A VWD, based on history of abnormal bleeding, low plasma VWF:Ag and activity, low FVIII:C, and lack of plasma HMW VWF multimers. FamilyInfo: Proband of a pedigree (Fig. 1) with 5 affected individuals (V-2, III-3, IV-2, IV-3, IV-4) across multiple generations, all carrying the same variant; unaffected father (IV-5) does not carry it. ParentalGenotype(s): Mother (IV-4) heterozygous for the variant, affected. Father (IV-5) does not carry the variant, unaffected (normal VWF:Ag 95.2 IU/dL, normal multimer pattern). CasePresentingHPOs: HP:0000421 (Epistaxis), HP:0001934 (Persistent bleeding after trauma — "prolonged bleedings from small wounds"), HP:0012147 (Reduced quantity of VWF; VWF:Ag 20.5 U/dL), HP:0030129 (Impaired VWF:RCo; VWF:Rco 6.2 U/dL), HP:0030132 (Absence of large VWF multimers — plasma), HP:0011871 (Impaired RIPA; 28.5%), HP:0003645 (Prolonged partial thromboplastin time; APTT 58.1 sec) CaseHPOFreeText: Frequent bruising, delayed wound healing (no matching HPO code in the approved list); FVIII:C 25.0 U/dL (nv 50-150); TT 16.7 sec and PT 14.2 sec both within normal range. CaseNOTHPOs: NA CaseNOTHPOFreeText: Platelet-associated VWF multimers were normal (HMW multimers present, indistinguishable from controls) despite the plasma multimer defect — supports a secretion defect rather than a synthesis defect. CasePreviousTesting: Not genome-wide; targeted VWF gene analysis — Sanger sequencing of all 52 exons and intron-exon boundaries of VWF using published primers, followed by allele-specific cloning (pMD18-T vector) and sequencing to resolve the heterozygous deletion. GenotypingMethod: Direct Sanger sequencing (Applied Biosystems 310 DNA analyzer) of all VWF exons/boundaries; PCR amplification and cloning of individual alleles into pMD18-T vector to confirm and characterize the heterozygous deletion. PreviouslyPublished: NA — first report of this variant/family. Gene: VWF Variant: Novel heterozygous in-frame 6-bp deletion in exon 28, removing residues D1529 and V1530 (ΔD1529V1530) in the VWF A2 domain. Functional studies (HEK293 transfection) showed the mutant is expressed but its secretion is markedly impaired (42±4% of WT in conditioned medium, p<0.01) with intracellular retention (174±29% of WT in cell lysate, p<0.05) and ER colocalization (PDI co-staining); co-transfection with WT VWF reduced WT secretion (61±16% of WT alone, p<0.05), indicating a dominant-negative effect. Classified as a "Group I" type 2A mechanism (impaired intracellular transport/secretion). HGVS: c.4585_4590del (p.Asp1529_Val1530del) — confirmed against the authors' GenBank submission (JN625247) and cross-validated against a real ClinVar-confirmed exon 28 variant ClinVarID: NA CAID: NA gnomAD: NA
Identification and Functional Analysis of a Novel von Willebrand Factor Mutation in a Family with Type 2A von Willebrand Disease
PMID: 22479377 Gene: VWF HGNCID: HGNC:12726
homozygous c.2311A>G
Gene:VWF
HGNCID:12726
Case:11 yo female
DiseaseAssertion: Type 2N
FamilyInfo:Fig. 1, family 1, patient 4
ParentalGenotype(s):Unknown, obligate carriers
CasePresentingHPOs:HP:0000421, HP:0012147 HP:0030132, HP:0030130
CaseHPOFreeRext:Oral cavity and joint bleeding, Bleeding from small wounds and after tooth extraction, VWF:Ag 0.07 U/mL, VWF:Ac 0.08 U/mL, VWF:CB <0.05 U/mL, FVIII 0.01 U/mL, No VWF Multimers
GenotypingMethod: NGS
Gene:VWF
Variant:c.2311A>G
HGVS:NM_000552.5(VWF):c.2311A>G
ClinVarID:1065273
CAID:CA383522481
homozygous c.2311A>G
Gene:VWF
HGNCID:12726
Case:29 yo female
DiseaseAssertion: Type 2N
FamilyInfo:Fig. 1, family 1, patient 1
ParentalGenotype(s):Unknown, obligate carriers
CasePresentingHPOs:HP:0000421, HP:0000132, HP:0012147 HP:0030132, HP:0030130
CaseHPOFreeRext:Skin, GI, muscle, oral cavity, and joint bleeding, VWF: Ag 0.07 U/mL, VWF:Ac 0.08 U/mL, VWF:CB 0.05 U/mL, FVIII 0.02 U/mL, No VWF Multimers
GenotypingMethod: NGS
Gene:VWF
Variant:c.2311A>G
HGVS:NM_000552.5(VWF):c.2311A>G
ClinVarID:1065273
CAID:CA383522481
97 10 F 45 c.7604G.Ap.R2535Q Hmz 9 2.3 6 - -
Case: 97, F, 10 years, Indian
DiseaseAssertion: VWD type 3
FamilyInfo: no family history of disease, Consanguinity: no
ParentalGenotype: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: FVIII:C: (U/dl): 9, VWF:Ag (U/dl): 2.3, Bleeding Score: 6
CaseNotHPOs: n/a
CaseNotHPOFreeText: n/a
CasePreviousTesting: n/a
Gene: VWF
Variant:
c.7604G>A (p.Arg2535Gln), Exon 45
Homozygous
19 1.3 F 45 c.7725_7729delCTGTGp.R2575_E2577del Htz 3.6 1 4 + -
Case: 19, F, 1.3 years, Indian
DiseaseAssertion: VWD type 3
FamilyInfo:family history of disease, Consanguinity: no
ParentalGenotype: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: FVIII:C: (U/dl): 3.6, VWF:Ag (U/dl): 1, Bleeding Score: 4
CaseNotHPOs: n/a
CaseNotHPOFreeText: n/a
CasePreviousTesting: n/a
Gene: VWF
Variant:
c.7725_7729delCTGTG (p.Arg2575_Glu2577del), Exon 45, Heterozygous
10 42 M 20 c.2560C.T p.R854W Htz ,1 ,1 34 + -
Case: 10, M, 42 years, Indian
DiseaseAssertion: VWD type 3
FamilyInfo: family history of disease, Consanguinity: no
ParentalGenotype: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: FVIII:C: (U/dl): <1, VWF:Ag (U/dl): <1, Bleeding Score: 34
CaseNotHPOs: n/a
CaseNotHPOFreeText: n/a
CasePreviousTesting: n/a
Gene: VWF
Variant:
c.2560C>T (p.Arg854Trp), Exon 20
Heterozygous
38 Type2A(IIA)c.4589T>GN p.Val1530Gly 28 A2 htz Missense na 30 na na
Case: IP #38 (also in row 18 table 6)
DiseaseAssertion: type 2A (IIA) VWD
FamilyInfo:
ParentalGenotype(s):
CasePresentingHPOs:
CaseHPOFreeRext:
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting:
GenotypingMethod: Sequence variations in the VWF were identified through direct sequencing, while the detection of large rearrangements utilized the multiplex ligation-dependent probe amplification (MLPA) technique or assessed copy number variations (CNVs). Sanger sequencing methodology was applied for VWF analysis in patients investigated prior to 2016 (approximately 14% of IPs), whereas next-generation sequencing (NGS) was employed for the analysis of VWF in patients inspected from 2017 onwards (about 86% of IPs). In both strategies, the entire VWF, encompassing all 52 exons, intron/exon boundaries, and promoter regions, was analyzed.
PreviouslyPublished:
Gene: VWF
Variant: c.4589T>G p.Val1530Gly
HGVS:
ClinVarID: not found
CAID: CA383501045
gnomAD: absent
10-12Type2A (IIE)c.3296G>AN p.Cys1099Tyr 25 D3-C8-3htz Missense O/na/A131/na/26532/na/44 117OSCA/na
Case: IP #11 (also in row 6 table 6)
DiseaseAssertion: type 2A (IIE) VWD
FamilyInfo:
ParentalGenotype(s):
CasePresentingHPOs:
CaseHPOFreeRext:
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting:
GenotypingMethod: Sequence variations in the VWF were identified through direct sequencing, while the detection of large rearrangements utilized the multiplex ligation-dependent probe amplification (MLPA) technique or assessed copy number variations (CNVs). Sanger sequencing methodology was applied for VWF analysis in patients investigated prior to 2016 (approximately 14% of IPs), whereas next-generation sequencing (NGS) was employed for the analysis of VWF in patients inspected from 2017 onwards (about 86% of IPs). In both strategies, the entire VWF, encompassing all 52 exons, intron/exon boundaries, and promoter regions, was analyzed.
PreviouslyPublished:
Gene: VWF
Variant: c.3296G>A p.Cys1099Tyr
HGVS:
ClinVarID: not found
CAID: CA383512195
gnomAD: absent
51-54Type2A(IIA)c.4811T>AN p.Val1604Asp 28 A2 htz Missense O/A/O/O27/24/35/328/9/11/755CSA/57
Case: IP #52 (also in row 21 table 6)
DiseaseAssertion: type 2A (IIA) VWD
FamilyInfo:
ParentalGenotype(s):
CasePresentingHPOs: HP:0032370 - blood group A
CaseHPOFreeRext: VWF:Ag [IU/dL] = 24; VWF:Ac [IU/dL] = 9; FVIII:C [IU/dL] = 57
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting:
GenotypingMethod: Sequence variations in the VWF were identified through direct sequencing, while the detection of large rearrangements utilized the multiplex ligation-dependent probe amplification (MLPA) technique or assessed copy number variations (CNVs). Sanger sequencing methodology was applied for VWF analysis in patients investigated prior to 2016 (approximately 14% of IPs), whereas next-generation sequencing (NGS) was employed for the analysis of VWF in patients inspected from 2017 onwards (about 86% of IPs). In both strategies, the entire VWF, encompassing all 52 exons, intron/exon boundaries, and promoter regions, was analyzed.
PreviouslyPublished:
Gene: VWF
Variant: c.4811T>A p.Val1604Asp
HGVS:
ClinVarID: not found
CAID: CA383499144
gnomAD: absent
Case#: 23015, Age 74, Male, Blood Type A+ (Table S3)
Disease Assertion: VWD1
FamilyInfo: The patient is the only member of Family# 2310.
Parental Genotype: Not listed
CasePresentingHPOs: N/A
CaseHPOFreeText:VWF:Ag: 18, VWF:RCo:17.3, FVIII:C:19, VWF:CB:13
CaseNotHPOs: N/A
CaseNotHPOFreeText: Bleeding Score 3
Protein Expression: N/A
CasePreviousTesting: 48,48 Access-Array amplification. NGS Molecular analysis was performed. Sanger sequencing was used to validate selected mutations
Gene: VWF
Variant: NM_000552.4:c.2546+132G>A(p.=) and NM_000552.4:c.3614G>A (p.Arg1205His)
ClinVar: 308 ClinVar
CAID: CA232299449 and CA114160 CAID1 CAID2
gnomAD: MAF of 0.001179 ( 1/848 alleles) in the Latino population (CA232299449). gnomAD
Case#: 01010, Age 55, Male, Blood Type O+ (Table S3)
Disease Assertion:VWD1
FamilyInfo: Not listed
Parental Genotype:Not listed
CasePresentingHPOs:
CaseHPOFreeText: Bleeding score 5, VWF:Ag 27, VWF:RCo: 30, FVIII:C 51, VWF:CB: 32
CaseNotHPOs:
CaseNotHPOFreeText:
Protein Expression:
CasePreviousTesting: 48,48 Access-Array amplification. NGS Molecular analysis was performed. Sanger sequencing was used to validate selected mutations.
Gene: VWF
Variant:NM_000552.4(VWF):c.4751A>G (p.Tyr1584Cys)
ClinVar: 310
CAID: CA114162
gnomAD: MAF of 0.004024 (519/128972 alleles) in the European (non-Finnish) population.
Case#: 32005, Age 28, Female, Blood Type O- (Table S3)
Disease Assertion: VWD 1
FamilyInfo: The patient is the only member of Family# 3205.
Parental Genotype: Not listed
CasePresentingHPOs: N/A
CaseHPOFreeText: VWF:Ag: 30, VWF:RCo: 25, FVIII:C: 25, VWF:CB: 32
CaseNotHPOs: N/A
CaseNotHPOFreeText: Bleeding Score 4
Protein Expression: N/A
CasePreviousTesting: 48,48 Access-Array amplification. NGS Molecular analysis was performed. Sanger sequencing was used to validate selected mutations.
Gene: VWF
Variant: NM_000552.4:c.2546+132G>A (p.=) and NM_000552.4:c.4751A>G (p.Tyr1584Cys)
ClinVar: 310
CAID: CA232299449 and CA114162 CAID1 CAID2
gnomAD: MAF of 0.001179 (1/848 alleles) in the Latino population (CA232299449) gnomAD
MAF of 0.004024 (519/ 128972 alleles) in the European (non-Finnish) population. gnomAD
Case#: 02023, Age 28, Female, Blood type O+ (Table S3)
Disease Assertion: VWD 1
FamilyInfo: Family# 0206. 3 family members were included in the study. Everyone in the family have the same variant and all have type 1 VWD.
Parental Genotype: Not listed
CasePresentingHPOs:
CaseHPOFreeText: Bleeding score 18, VWF:Ag: 5.5, VWF:RCo: 8, FVIII:C: 11, VWF:CB: 4.2
CaseNotHPOs:
CaseNotHPOFreeText:
Protein Expression:
CasePreviousTesting: 48,48 Access-Array amplification. NGS Molecular analysis was performed. Sanger sequencing was used to validate selected mutations.
Gene: VWF
Variant: NM_000552.4:c.3614G>A (p.Arg1205His)
ClinVar: 308 ClinVar
CAID: CA114160 CAID
gnomAD: N/A
Case#: 27018, Age 31, Male, Blood Type O+ (Table S3)
Disease Assertion: VWD 1
FamilyInfo: The patient is one out of two members of Family#2709. Both patients variants were not determined.
Parental Genotype: Not listed
CasePresentingHPOs: N/A
CaseHPOFreeText: VWF:Ag:27, VWF:RCo:28.5, FVIII:C:59, VWF:CB:25
CaseNotHPOs: N/A
CaseNotHPOFreeText: Bleeding Score 2
Protein Expression: N/A
CasePreviousTesting: 48,48 Access-Array amplification. NGS Molecular analysis was performed. Sanger sequencing was used to validate selected mutations.
Gene: VWF
Variant: Not determined
ClinVar: N/A
CAID: N/A
gnomAD: N/A
Case: Patient E
DiseaseAssertion: VWD2N
FamilyInfo: Family 4
ParentalGenotype(s):
CasePresentingHPOs: HP:0012147, HP:0030129, HP:0030130, HP:0011871
CaseHPOFreeText: PTsec = 38.1, FVIII U/dL = 19.8, FVIII ratio = 0.42, VWF:Ag U/dL = 46.6, VWF:FVIIIB U/dL = 7.7, VWF:FVIIIB ratio = 0.16, VWF:CB U/dL = 44.8, VWF:RCo U/dL = 51.9, RIPA % = 64.8, PlatVWF:Ag U/dL = 60.6
CaseNOTHPOs:
CaseNOTHPOFreeText: n/a
CasePreviousTesting: n/a
GenotypingMethod: "Genetic analysis was performed on exons 17-20 of the VWF gene as previously described" (PMID: 12393698)
PreviouslyPublished: n/a
Gene: VWF
Variant1: c.2561G>A (p.Arg854Gln)
HGVS: NM_000552.5(VWF):c.2561G>A (p.Arg854Gln)
ClinVarID: 296; https://www.ncbi.nlm.nih.gov/clinvar/variation/296/?new_evidence=false
CAID: n/a
gnomAD: MAF (European, Finnish) = 0.005692; https://gnomad.broadinstitute.org/variant/12-6143978-C-T
Variant2:
I : 1
Case#: F7, I:1
DiseaseAssertion: Type 2 VWD
CaseHPOFreeText: partial loss of high molecular weight multimers, VWF:Ag = 88; VWF:RCo = 46; VWF:GPIbM = 81; 0.52; 0.93; 1.77
CasePreviousTesting: Not clearly described
Gene: VWF
Variant: p.[I1309V];[=]
HGVS: c.3925A>G (p.Ile1309Val)
CAID: CA228492
gnomAD: absent from gnomad v4.1.0
I : 1
Case#: F6, I:1
DiseaseAssertion: Type 2 VWD
CaseHPOFreeText: partial loss of high molecular weight multimers, VWF:Ag = 56; VWF:RCo = 29; VWF:GPIbM = 75; 0.51; 1.34; 2.63
CasePreviousTesting: Not clearly described
Gene: VWF
Variant: p.[H1268D];[=]
HGVS: c.3802C>G (p.His1268Asp)
CAID: CA228445
gnomAD: absent from gnomad v4.1.0
I : 1
Case#: F20, I:1
DiseaseAssertion: Type 2 VWD
CaseHPOFreeText: loss of high and intermediate MWMs, VWF:Ag = 34; VWF:RCo = 8; VWF:GPIbM = 23; 0.22; 0.68; 3.08
CasePreviousTesting: Not clearly described
Gene: VWF
Variant: p.[V1316M];[=]
HGVS: c.3946G>A (p.Val1316Met)
CAID: CA114127
gnomAD: absent from gnomad v4.1.0
II : 1
Case#: F5, II:1
DiseaseAssertion: Type 2 VWD
CaseHPOFreeText: all mutimers present, VWF:Ag = 56; VWF:RCo = 48; VWF:GPIbM = 49; 0.86; 0.87; 1.01
CasePreviousTesting: Not clearly described
Gene: VWF
Variant: p.[I1372S];[=]
HGVS: c.4115T>G (p.Ile1372Ser)
CAID: CA228535
gnomAD: https://gnomad.broadinstitute.org/variant/12-6019303-A-C?dataset=gnomad_r4
I : 1
Case#: F19, I:1
DiseaseAssertion: Type 2 VWD
CaseHPOFreeText: loss of high and intermediate MWMs, VWF:Ag = 35; VWF:RCo = 5; VWF:GPIbM = 28; 0.14; 0.81; 5.68
CasePreviousTesting: Not clearly described
Gene: VWF
Variant: p.[V1316M];[=]
HGVS: c.3946G>A (p.Val1316Met)
CAID: CA114127
gnomAD: absent from gnomad v4.1.0
Safety of a pasteurized plasma‐derived Factor VIII and von Willebrand factor concentrate: analysis of 33 years of pharmacovigilance data
PMID: 28691218
Gene: VWF
HGNCID: 12726
von Willebrand disease
Gene: VWF
PMID: 9299039
22*IranF/361—YesSevere4975C→TR1659X28HomozygousDdeI (+)
Case: 22, F, 36, Iranian
DiseaseAssertion: VWD type 3
FamilyInfo: Consanguinity: Yes
ParentalGenotype: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: VWF:Ag (U/dl): 1, Bleeding symptoms: Severe
CaseNotHPOs: n/a
CaseNotHPOFreeText: Anti-VWF alloantibodies: no
CasePreviousTesting: n/a
Gene: VWF
Variant:
4975C→T (Arg1659X), Exon 28, Homozygous
14*IranF/262—YesSevere652C→TQ218X6HomozygousN.A.
Case: 14, F, 26, Iranian
DiseaseAssertion: VWD type 3
FamilyInfo: Consanguinity: Yes
ParentalGenotype: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: VWF:Ag (U/dl): 2, Bleeding symptoms: Severe
CaseNotHPOs: n/a
CaseNotHPOFreeText: Anti-VWF alloantibodies: no
CasePreviousTesting: n/a
Gene: VWF
Variant:
652C→T (Gln218X), Exon 6, Homozygous
33IndiaF/24<1—YesMild7137insTFS42HomozygousN.A.
Case: 33, F, 24, Indian
DiseaseAssertion: VWD type 3
FamilyInfo: Consanguinity: Yes
ParentalGenotype: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: VWF:Ag (U/dl): <1, Bleeding symptoms: Mild
CaseNotHPOs: n/a
CaseNotHPOFreeText: Anti-VWF alloantibodies: no
CasePreviousTesting: n/a
Gene: VWF
Variant:
7137insT (FS), Exon 42, Homozygous
38IndiaF/25<1—NoMild3379+1G→A/4414insCFS/FS25/28HeterozygousNlaIII (+)/N.A.
Case: 38, F, 25, Indian
DiseaseAssertion: VWD type 3
FamilyInfo: Consanguinity: No
ParentalGenotype: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: VWF:Ag (U/dl): <1, Bleeding symptoms: Mild
CaseNotHPOs: n/a
CaseNotHPOFreeText: Anti-VWF alloantibodies: no
CasePreviousTesting: n/a
Gene: VWF
Variant:
3379+1G→A (intronic), Exon 25
4414insC (FS), Exon 28
Compound Heterozygous
Note: The authors assume that 3379+1G→A causes a frameshift mutation. No potential splice site mutation was confirmed at the mRNA level; “Splice Site Prediction program” found all mutations likely to disrupt normal splicing. No possible splice site mutation could be identified on 100 chromosomes from a group of 50 normal subjects with same genetic background as patients, excluding the possibility that these mutations represent common polymorphisms.
Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden
PMID: 1419803
Gene: VWF
HGNC: 12726
Disease: von Willebrand disease type 2B
MONDO: 0015629
InheritancePattern: Autosomal Dominant
Prevalence: Overall VWD prevalence is estimated to be as high as 1 in 100 in the general population, with 1 in 10,000 pursuing tertiary care referral ((PMID: 28847738).
Penetrance: Fully penetrant / nearly fully penetrant for most pathogenic type 2 variants
Phenotypic and genotypic (exon 28) characterization of patients diagnosed with von Willebrand disease type 1 in Eastern Saudi Arabia
PMID: 37168293
Gene: VWF
HGNCID: 12726
PMID: 20409624
Gene: VWF
HGNC: 12726
Disease: von Willebrand disease type 2M
MONDO: 0015630
InheritancePattern: Autosomal Dominant
Prevalence: Overall VWD prevalence is estimated to be as high as 1 in 100 in the general population, with 1 in 10,000 pursuing tertiary care referral ((PMID: 28847738).
Penetrance: Fully penetrant / nearly fully penetrant for most pathogenic type 2 variants
Plasma levels of plasminogen activator inhibitor‐1 and bleeding phenotype in patients with von Willebrand disease
PMID: 28306198
Gene: VWF
HGNCID: 12726
6
Case: Patient 6 (Family B), male, 15yo
DiseaseAssertion: VWD2B
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs: HP:0030132, HP:0030129, HP:0030130, HP:0011871, HP:0012147
(Absence of large von Willebrand factor multimers, impaired ristocetin cofactor assay activity, Impaired von Willebrand factor collagen binding activity, Impaired RIPA, Reduced quantity of VWF)
CaseHPOFreeText: blood group A, Platelet count x103/μl = 180, PFA 100 sec = >300, SPA % = 0, MADR mg/mL = 0.6, VWF:Ag U/dL = 30.9, VWF:CB U/dL = 12.5, VWF:CB ratio = 0.41, VWF:RCo U/dL = 11.4, VWF:RCo ratio = 0.37, Platelet VWF U/dL = 79.1, FVIII U/dL = 49.3, BAT F/M = 4
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting: NA
GenotypingMethod: Sequencing of exon 28 of VWF
PreviouslyPublished: NA
Gene: VWF
Variant: c.3922C>T (p.Arg1308Cys)
HGVS: NM_000552.4(VWF):c.3922C>T (p.Arg1308Cys)
ClinVarID: 289; https://www.ncbi.nlm.nih.gov/clinvar/variation/289/
CAID: NA
gnomAD: absent
1
Case: Patient 1 (Family A), female, 48yo
DiseaseAssertion: VWD2B
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs: HP:0030129, HP:0030130, HP:0011871, HP:0012147
(impaired ristocetin cofactor assay activity, Impaired von Willebrand factor collagen binding activity, Impaired RIPA, Reduced quantity of VWF)
CaseHPOFreeText: blood group A, Platelet count x103/μl = 232, PFA 100 sec = NA, SPA % = 12, MADR mg/mL = 0.45, VWF:Ag U/dL = 160.6, VWF:CB U/dL = 135.6, VWF:CB ratio = 0.84, VWF:RCo U/dL = 132.8, VWF:RCo ratio = 0.83, Platelet VWF U/dL = 92.0, FVIII U/dL = 78.0, BAT F/M = 6
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting: NA
GenotypingMethod: Sequencing of exon 28 of VWF
PreviouslyPublished: NA
Gene: VWF
Variant: c.4115T>G (p.Ile1372Ser)
HGVS: NM_000552.4(VWF):c.4115T>G (p.Ile1372Ser)
ClinVarID: 100327; https://www.ncbi.nlm.nih.gov/clinvar/variation/100327/
gnomAD: MAF = 0.00006175 (7/113356 alleles) in the European (non-Finnish) population; https://gnomad.broadinstitute.org/variant/12-6128469-A-C?dataset=gnomad_r2_1
11
Case: Patient 11 (Family C), male, 80yo
DiseaseAssertion: VWD2B
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs: HP:0030132, HP:0030129, HP:0030130, HP:0011871, HP:0012147
(Absence of large von Willebrand factor multimers, impaired ristocetin cofactor assay activity, Impaired von Willebrand factor collagen binding activity, Impaired RIPA, Reduced quantity of VWF)
CaseHPOFreeText: blood group O, Platelet count x103/μl = 182, PFA 100 sec = >300, SPA % = 0, MADR mg/mL = 0.45, VWF:Ag U/dL = 39.5, VWF:CB U/dL = 9.3, VWF:CB ratio = 0.24, VWF:RCo U/dL = 23.3, VWF:RCo ratio = 0.59, Platelet VWF U/dL = 113.90, FVIII U/dL = 52.1, BAT F/M = 14
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting: NA
GenotypingMethod: Sequencing of exon 28 of VWF
PreviouslyPublished: NA
Gene: VWF
Variant: c.3922C>T (p.Arg1308Cys)
HGVS: NM_000552.4(VWF):c.3922C>T (p.Arg1308Cys)
ClinVarID: 289; https://www.ncbi.nlm.nih.gov/clinvar/variation/289/
CAID: NA
gnomAD: absent
heterozygous small deletion (p.Leu 757ValfsX22) together with a large deletion of exons 48–52
Case: IP-4
DiseaseAssertion: VWD3
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs:
CaseHPOFreeRext: VWF:Ag 3%
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting: Direct sequencing of exons 2–52 including exon/intron boundaries of the VWF gene
GenotypingMethod: multiple ligation‐dependent probe amplification (MLPA; using kit P011 and P012; MRC Holland, Amsterdam, the Netherlands) according to the manufacturer’s instructions. The PCR products were run on an ABI PRISM 3130XL sequencer with the GeneScan 500 LIZ size standard and analyzed using GeneMapper Software 5.0 (Applied Biosystems, Darmstadt, Germany). Dosage analysis based on a comparison between deleted and reference wild‐type DNA samples was performed using the Excel‐based software Coffalyser V9.4 (MRC Holland).
PreviouslyPublished: NA
Gene: VWF
Variant: p.Leu757ValfsX22
HGVS:
ClinVarID:
CAID:
gnomAD:
MultipleGeneVariants:
GeneName: VWF
Variant: deletion of exons 48-52
ClinVarID or CAID:
gnomAD:
homozygous large deletion of exon 6
Case: IP-1
DiseaseAssertion: VWD3
FamilyInfo: 6 additional family members, 5 heterozygous and 1 homozygous. All meet criteria of mild VWD1.
ParentalGenotype(s): NA
CasePresentingHPOs:
CaseHPOFreeRext: VWF antigen (VWF:Ag) of <1%, VWF ristocetin‐cofactor activity (VWF:RCo) of <6% and factor VIII activity (FVIII:C) of 5%
CaseNOTHPOs: NA
CaseNOTHPOFreeText: NA
CasePreviousTesting: Direct sequencing of exons 2–52 including exon/intron boundaries of the VWF gene
GenotypingMethod: multiple ligation‐dependent probe amplification (MLPA; using kit P011 and P012; MRC Holland, Amsterdam, the Netherlands) according to the manufacturer’s instructions. The PCR products were run on an ABI PRISM 3130XL sequencer with the GeneScan 500 LIZ size standard and analyzed using GeneMapper Software 5.0 (Applied Biosystems, Darmstadt, Germany). Dosage analysis based on a comparison between deleted and reference wild‐type DNA samples was performed using the Excel‐based software Coffalyser V9.4 (MRC Holland).
PreviouslyPublished: NA
Gene: VWF
Variant: deletion of exon 6
HGVS:
ClinVarID:
CAID:
gnomAD:
1
Case: 2A-9
DiseaseAssertion: VWD2A
FamilyInfo:
ParentalGenotype(s):
CasePresentingHPOs: AcuStar RCo/Ag = 0.32; AcuStar CB/Ag = 0.34; ELISA CB/Ag = 0.40
CaseHPOFreeText:
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting:
GenotypingMethod: not described
PreviouslyPublished: PMID:20351307
Gene: VWF
Variant: c.3296G>A (p.Cys1099Tyr)
HGVS: NM_000552.5:c.3296G>A (p.Cys1099Tyr)
ClinVarID: n/a
CAID: CA383512195; https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA383512195
gnomAD: absent
1
Case: 2A-8
DiseaseAssertion: VWD2A
FamilyInfo:
ParentalGenotype(s):
CasePresentingHPOs: AcuStar RCo/Ag = 0.43; AcuStar CB/Ag = 0.28; ELISA CB/Ag = 0.39
CaseHPOFreeText:
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting:
GenotypingMethod: not described
PreviouslyPublished: PMID:16985174
Gene: VWF
Variant: c.8313C>G (p.Cys2771Trp)
HGVS: NM_000552.5:c.8313C>G (p.Cys2771Trp)
ClinVarID: n/a
CAID: CA383486665; https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA383486665
gnomAD: absent
T001
Case: T001, M, 42
DiseaseAssertion: VWD type 3
FamilyInfo: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: Bleeding Score: 19 (Kruskal–Wallis followed by Mann–Whitney U post-hoc testing Post-hoc testing ), VWF:Ag (IU/ml): 0.01, VWF:RCo (IU/ml): 0.02, FVIII:C (IU/ml) : 0.02
CaseNotHPOs: n/a
CaseNotHPOFreeText: n/a
CasePreviousTesting: n/a
Gene: VWF
Variant:
c.221-977_532 + 7059del (p.Asp75_Gly178del), Exon 4-5, Homozygous
Note: ELISA-based assay for detecting alloantibodies, genomic analysis via sequencing of leukocytes for the VWF gene including exons 1-52 and about 1.5 km of VWF promoter, PCR amplification for variant confirmation, SALSA-MLPAVWF assay evaluation for partial/total gene deletions when sequencing did not reveal pathogenic explanation
T116F/2960.020.040.02c.8418_8419insTCCCp.Ser2807 fs52Homozygous
Case: T116, F, 29
DiseaseAssertion: VWD type 3
FamilyInfo: n/a
CasePresentingHPOs: n/a
CaseHPOFreeText: Bleeding Score: 6 (Kruskal–Wallis followed by Mann–Whitney U post-hoc testing Post-hoc testing ), VWF:Ag (IU/ml): 0.02, VWF:RCo (IU/ml): 0.04, FVIII:C (IU/ml): 0.02
CaseNotHPOs: n/a
CaseNotHPOFreeText: n/a
CasePreviousTesting: n/a
Gene: VWF
Variant:
c.8418_8419insTCCC (p.Ser2807 fs), Exon 52, Homozygous
Note: ELISA-based assay for detecting alloantibodies, genomic analysis via sequencing of leukocytes for the VWF gene including exons 1-52 and about 1.5 km of VWF promoter, PCR amplification for variant confirmation, SALSA-MLPAVWF assay evaluation for partial/total gene deletions when sequencing did not reveal pathogenic explanation
Case: P9, Chinese, male, 11yo
DiseaseAssertion: VWD1
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs: HP:0012147
(Reduced quantity of VWF)
CaseHPOFreeText: type A blood, bleeding score = 2; VWF:Ag (%) = 5.3, VWF:RCo (%) = 4.7, FVIII:C (%) = 10.7, VWF:CB (%) = 4.5, VWFpp (%) = 4.1, VWF:RCo/VWF:Ag = 0.9, VWF:CB/VWF:Ag = 0.9, VWFpp/VWF:Ag = 0.8, FVIII:C/VWF:Ag = 2.0, RIPA (1.2 mg/ml, %) = 51.0
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting: NA
GenotypingMethod: NGS
PreviouslyPublished: NA
Gene: VWF
Variant 1: c.4414G>C (p.Asp1472His)
HGVS: NM_000552.4(VWF):c.4414G>C (p.Asp1472His)
ClinVarID: 256679; https://www.ncbi.nlm.nih.gov/clinvar/variation/256679/
CAID: NA
gnomAD: MAF = 0.5077 (12039/23712 alleles; 3078 homozygotes) in the African/African-American population; https://gnomad.broadinstitute.org/variant/12-6128170-C-G?dataset=gnomad_r2_1
Variant 2: c.8079C>A (p.Cys2693Ter)
HGVS: NM_000552.5:c.8079C>A (p.Cys2693Ter)
ClinVarID: NA
CAID: CA383487414; http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA383487414
gnomAD: absent
Case: P78, Chinese, female, 23yo
DiseaseAssertion: VWD3
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs: HP:0012147
(Reduced quantity of VWF)
CaseHPOFreeText: type O blood, bleeding score = 13; VWF:Ag (%) = <0.3, VWF:RCo (%) = <0.5, FVIII:C (%) = 4.3, VWF:CB (%) = <0.5, VWFpp (%) = <0.5, VWF:RCo/VWF:Ag = NA, VWF:CB/VWF:Ag = NA, VWFpp/VWF:Ag = NA, FVIII:C/VWF:Ag = NA
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting: NA
GenotypingMethod: NGS
PreviouslyPublished: NA
Gene: VWF
Variant: c.5183_5186del - unregistered variant
HGVS: NA
ClinVarID: NA
CAID: NA
gnomAD: NA
Case: P75, Chinese, female, 25yo
DiseaseAssertion: VWD1
FamilyInfo: NA
ParentalGenotype(s): NA
CasePresentingHPOs: HP:0012147
(Reduced quantity of VWF)
CaseHPOFreeText: type O blood, bleeding score = 2; VWF:Ag (%) = 53.6, VWF:RCo (%) = 55.9, FVIII:C (%) = 74.0, VWF:CB (%) = 53.8, VWFpp (%) = 57.7, VWF:RCo/VWF:Ag = 1.0, VWF:CB/VWF:Ag = 1.0, VWFpp/VWF:Ag = 1.1, FVIII:C/VWF:Ag = 1.4
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting: NA
GenotypingMethod: NGS
PreviouslyPublished: NA
Gene: VWF
Variant: c.6104G>A (p.Gly2035Asp)
HGVS: NM_000552.3:c.6104G>A (p.Gly2035Asp)
ClinVarID: NA
CAID: CA6402069; http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA6402069
gnomAD: MAF = 0.005613 (112/19954 alleles; 2 homozygotes) in the East Asian population; https://gnomad.broadinstitute.org/variant/12-6103733-C-T
The S1285F mutation alters the folding of A1 loop and avoids the exposure of the VWF protein to platelets. This substitution was detected in a 2M patient and her mother.
Efficacy and safety of a VWF/FVIII concentrate (wilate ® ) in inherited von Willebrand disease patients undergoing surgical procedures
PMID: 28026130
Gene: VWF
HGNCID: 12726
660
Case#: Ahmad_2014_660
DiseaseAssertion: VWD type 2A
FamilyInfo: heterozygous (probably affected according to multimer analysis) mother and sibling
ParentalGenotype: heterozygous mother and sibling, homozygous wt father
CasePresentingHPOs: none described
CaseHPOFreeText: none described
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting: not reported
GenotypingMethod: PCR, restriction digest
Gene: VWF
Variant: NM_000552.5(VWF):c.4883T>C (p.Ile1628Thr)
HGVS:
ClinVarID: 284
CAID:
gnomAD: not reported
MultipleGeneVariants:
Haemostatic patterns and bleeding scores of a genetically characterised Italian family with combined haemophilia A and type 1 von Willebrand disease
PMID: 27380589
Gene: VWF
HGNCID: 12726
Case 1
Case: Case 1, female, newborn
DiseaseAssertion: VWD2B
FamilyInfo: 2nd child of couple without family history of bleeding; Analysis of platelet genotype for HPA-1, 2, 3, 5, and HPA-15 alleles by PCR-SSP performed in both parents showed a possible incompatibility in HPA-1b and HPA-5b; No maternal anti-HPA antibody was detected using monoclonal antibody-specific immobilization of platelet antigen method directed against HPA-1, 3, 4, HPA-2, and HPA-5 antigens
ParentalGenotype(s): Variant absent from both parents
CasePresentingHPOs: HP:0001873, HP:0000967, HP:0030129
(Thrombocytopenia, petechia, impaired ristocetin cofactor assay activity)
CaseHPOFreeText: born at 40wks, Detection of maternal alloantibodies against HPA antigens present on paternal platelets showed weak cross reactivity, VWF:RCo = 8 IU dL−1, VWF:RCo/VWF:Ag < 0.1, FVIII:C = 94 IU dL−1, RIPA could not be performed due to low platelet count
CaseNOTHPOs: HP:0032169
(infection)
CaseNOTHPOFreeText: DIC, spontaneous bleeding
CasePreviousTesting: NA
GenotypingMethod: sequencing of the whole exon 28 of VWF gene
PreviouslyPublished: NA
Gene: VWF
Variant: c.4379T>C (p.Leu1460Pro)
HGVS: NM_000552.3:c.4379T>C (p.Leu1460Pro)
ClinVarID:
CAID:
gnomAD:
Potential misdiagnosis of von Willebrand disease and haemophilia caused by ineffective mixing of thawed plasma
PMID: 28750474
Gene: VWF
HGNCID: 12726
AII:1
Proband: FA_II:1, male uknown age
FamilyDetails: heterozygous unaffected parents, parents were first cousins, VWF:Ag on low end of reference range
Labs: prolonged bleeding time (15min), reduced VWF:Ag (0.06 IU/mL), FVIII:Ag (0.18 IU/mL), FVIII:C (0.20 IU/mL), and VWF:RiCoF (0.06 IU/mL), absent multimers
Genotype: p.Arg273Trp reported as c.1067C>T (MANE transcript is 817C>T)
CAID: CA228829
His 30‐year‐old mother had epistaxis, easy bruising, gum bleeding, and abnormal menstrual score according to the Pictorial Bleeding Assessment Chart4 (PBAC = 192, nv < 185).
Case#: 2, Female, Age 30, blood type B, Mother of Proband
Disease Assertion: VWD1
FamilyInfo: Mother of proband, No family history
Parental Genotype: not listed
CasePresentingHPOs: HP:0000421, HP:0000978, HP:0000225
(Epistaxis, Bruising susceptibility, Gingival bleeding)
CaseHPOFreeText: abnormal menstrual score (PBAC= 192, nv<185), VWF:Ag: 45, VWF:RCo: 46, bleeding score 5
CaseNotHPOs:
CaseNotHPOFreeText:
Protein Expression:
CasePreviousTesting: Forward and reverse strands sequenced by automated sequencing technology, PCR techniques used to analyze exons 17, 26-31, and 52 of VWF gene
Gene: VWF
Variant:NM_000552.3:c.4276C>T (p.Arg1426Cys)
ClinVar:. N/A
CAID: CA6402561 CA6402561
gnomAD: MAF of 0.00006152 (1/16254 alleles) in the African population for CA6402561.
Case 12
Case: Case 12, ages 2-17, Croatian
DiseaseAssertion: VWD2A
FamilyInfo:
ParentalGenotypes(s):
CasePresentingHPOs:
CaseHPOFreeText:
CaseNOTHPOs:
CaseNOTHPOFreeText: bleeding score= 7, VWF:GPIbM (%)= 25.7, VWF:Ag (%)= 47.7, vWF:GPIbM/vWF:Ag ratio= 0.54, FVIII:C (%): 64, VWF: CBA (%)= 39.2
CasePreviousTesting:
Gene: VWF
Variant: c.4717G>A, p.Gly1573Ser
HGVS: NM_000552.5:c.4717G>A
ClinVar: 100384
gnomAD: https://gnomad.broadinstitute.org/variant/12-6127867-C-T?dataset=gnomad_r2_1
PT-VWD posing diagnostic and therapeutic challenges - small case series
PMID: 27819553
Gene: GP1BA
HGNCID: 4439
T3-1
Case: T3-1, female, 21yo
DiseaseAssertion: VWD3
FamilyInfo:
ParentalGenotype(s):
CasePresentingHPOs:
CaseHPOFreeText: Blood type: O+, bleeding score = 24, VWF:Ag (IU/mL) = 0.01; VWF:RCo (IU/mL) = 0.00; FVIII:C (IU/mL) = 0.01
CaseNOTHPOs:
CaseNOTHPOFreeText:
CasePreviousTesting:
GenotypingMethod: qRT-PCR
PreviouslyPublished:
Gene: VWF
Variant 1: c.876delC (p.Pro293Glnfs*164)
HGVS: n/a
ClinVarID: n/a
CAID: n/a
gnomAD: n/a
Variant 2: c.1255C>T (p.Gln419Ter)
HGVS: NM_000552.5:c.1255C>T (p.Gln419Ter)
ClinVarID: n/a
CAID: CA232314778; https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA232314778
gnomAD: absent
Development of a novel flow cytometric immunobead array to quantify VWF: Ag and VWF: GPIbR and its application in acute myocardial infarction
PMID: 28523822
Gene: VWF
HGNCID: 12726
A 23-year-old female patient
Case: Patient from family A, a 23-year-old female consanguineous Chinese patient
DiseaseAssertion: Type 3 von Willebrand disease
FamilyInfo: Patient's parents were cousins, both heterozygous carriers, who had also had a son that died at 1 year old from heavy nose bleeding; no other details given
ParentalGenotype(s): Heterozygous carriers, no details given as far as specific genotypes
CasePresentingHPOs: HP:0000132
Menorrhagia
CaseHPOFreeRext:"When she was 2 years old, scalp hematoma was observed." and severely decreased FVIII:C, VWF:Ag (FVIII:C: 1.3%, VWF:Ag: 3.6%, VWF:RCo: <1.0%)
CaseNOTHPOs: N/A
CaseNOTHPOFreeText: "No mutation was found in the F8 or F9 gene"
CasePreviousTesting: N/A
GenotypingMethod: NGS was performed targeting all exons and intronic flanking regions of the F8 (OMIM: * 300841, NM_000132.3), F9 (OMIM: * 300746, NM_000133.3), and VWF (OMIM: * 613160, NM_000552.4) genes; Some exons of VWF gene could not be discriminated from its highly homologous pseudogene, and these exons were sequenced by Sanger sequencing
Gene: VWF
Variant: Homozygous VWF c.4696C>T (p.Arg1566Ter) nonsense mutation
HGVS: NM_000552.5:c.4696C>T
ClinVarID: 100382
CAID: CA228639
gnomAD: MAF of 0.00001333 (1/74998 alleles) in the African/African American population
Case presentation A 27-year-old woman
Case: Proband, female, 27 years old at report; ethnicity not reported.
DiseaseAssertion: VWD2A. The authors confirmed type 2A VWD based on VWF:Ac/VWF:Ag ratio <0.7 (excluding types 1C, 2N, and 3), RIPA negative for increased platelet affinity (excluding type 2B), and multimer analysis showing HMWM deletion with IMWM reduction (excluding type 2M).
FamilyInfo: The patient denied a family history of abnormal bleeding. The father carried VWF c.2281+1G>A and was not diagnosed with VWD (VWF:Ag 61%, VWF:Ac 60.6%, FVIII activity 82%, VWF:Ac/VWF:Ag ratio 0.9). The mother carried VWF c.4654T>A and was diagnosed by the authors as having low VWF per British Committee for Standards in Haematology criteria (VWF:Ag 40%, VWF:Ac 26.6%, FVIII activity 66%, VWF:Ac/VWF:Ag ratio 0.6). Neither parent had a history of abnormal bleeding. Parental laboratory results and genotypes are reported in Table 2.
ParentalGenotype: Both parents were genotyped. The father was heterozygous for c.2281+1G>A and the mother was heterozygous for c.4654T>A (Table 2). The authors report that the two variants were inherited separately from each parent, establishing compound heterozygosity. Note: Figure 2 shows Sanger sequencing validation for c.2281+1G>A only, confirming the variant in the patient and father and a normal genotype at that locus in the mother. No confirmatory sequencing trace is shown for the maternal c.4654T>A variant; that genotype is reported only in Table 2.
CasePresentingHPOs: HP:0000421, HP:0000132, HP:0004846, HP:0012147, HP:0030132, HP:0011871 (Epistaxis, Menorrhagia, Prolonged bleeding after surgery, Reduced quantity of VWF, Absence of large von Willebrand factor multimers, Impaired RIPA)
CaseHPOFreeText: Gingival bleeding persisted for two days after tooth extraction. History of frequent epistaxis and one episode of heavy menorrhagia in 2007 treated with plasma transfusion. ISTH-BAT bleeding score 7 (epistaxis score 1, bleeding after tooth extraction score 2, heavy menorrhagia with plasma transfusion score 4). VWF:Ag 26.2%, VWF:Ac 5.7%, FVIII activity 43%, VWF:Ac/VWF:Ag ratio 0.21. Low-concentration RIPA 23.7% (reference 30.0-70.0%). VWF multimer analysis demonstrated deletion of high-molecular-weight multimers and reduction of intermediate-molecular-weight multimers (Figure 1). Arachidonic acid-induced platelet aggregation was impaired, with a maximal aggregation rate of 14.3%.
CaseNotHPOs: HP:0003645, HP:0001873 (Prolonged partial thromboplastin time, Thrombocytopenia)
CaseNotHPOFreeText: APTT 39.2 s (reference 32.0-45.0), platelets 183x10^9/L (reference 125-350), PT 13.6 s (reference 11.0-15.0), and fibrinogen 2.71 g/L (reference 2.0-4.0) were all within reference ranges, as was thrombin time. High-concentration RIPA 52.9% (reference 40.0-80.0), normal. Systemic physical examination unremarkable with no active bleeding on admission. Prior laparoscopic surgery for luteal rupture without a remarkable increase in bleeding. Hemoglobin 125 g/L was marginally below the stated reference range (130-175), although the authors described the complete blood count as normal.
CasePreviousTesting: Whole-exome sequencing was performed, which is a genome-wide method. No genes other than VWF were reported as tested or implicated. No earlier molecular genetic testing was reported.
GenotypingMethod: Whole-exome sequencing followed by one-generation (Sanger) sequencing validation, performed on the proband and both parents.
Variant 1
Gene: VWF
Variant: c.2281+1G>A, heterozygous, inherited from the father. Intron 17 canonical splice donor site; the authors describe the affected region as lying between the D2 and D' domains. Classified as pathogenic by the authors per ACMG guidelines.
HGVS: NM_000552.5:c.2281+1G>A
ClinVar: NA
CAID: CA383523243
gnomAD: Absent (gnomAD v4.1.1; variant not found, region adequately covered)
Variant 2
Gene: VWF
Variant: c.4654T>A (p.Phe1552Ile), heterozygous, inherited from the mother. Exon 28, A2 domain; missense. Classified as a variant of uncertain significance by the authors per ACMG guidelines. Note: the article gives the protein consequence as p.Phe1152Ile in the Case Presentation and p.Phe1552Ile in the Discussion; these are internally inconsistent. p.Phe1552Ile is correct, as confirmed by HGVS validation and by the ClinGen Allele Registry record (NP_000543.3:p.Phe1552Ile), and is consistent with the stated exon 28 location.
HGVS: NM_000552.5:c.4654T>A (p.Phe1552Ile)
ClinVar: NA
CAID: CA383500446
gnomAD: Absent (gnomAD v4.1.1; variant not found, region adequately covered)